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1
1. General Introduction
1.1 Introduction
In this chapter, we provide introductory information on glaucoma and the statistical
methods used to analyse visual field (VF) data. Both clinical and statistical parts are described
in a non-technical way to help the reader understand the basic concepts related to our research.
Furthermore, we introduce the motivating data set and explain the aims of this thesis.
1.2 The Human Eye
The human eye is an important organ which is responsible for vision. As seen in Figure
1.1, the anterior part of the eye consists of the iris, the cornea, the pupil, the lens and the
anterior chamber. The retina is part of the posterior part of the eye (shown in Figure 1.2).
The cornea and the lens focus the light into an image onto the retina. Visual impulses are
then transmitted from the retina to the brain via the optic nerve, which is made up of retinal
nerve cells and their fibres. The optic nerve head is the point where the ganglion cell axons
exit the eye. Since there are no rods or cones in the optic nerve head, this corresponds to a
small physiological blind spot in each eye. If any of the structures in the optical pathway are
blocked or the eye does not focus the light correctly, visual function will be disturbed. There
are several diseases which can affect visual function, such as diabetic retinopathy, cataract or
glaucoma.
Figure 1.1: Cross-section of the eye. Image courtesy of the National Eye Institute, National Institutes of
Health.
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A. B.
Figure 1.2: (A) Fundus photo of retina and (B) drawing of nerve fibres.
1.3 Glaucoma
The term "glaucoma" covers a wide range of diseases. According to the World Health
Organisation (WHO), glaucoma is one of the leading causes of irreversible blindness in
the world (Kingman, 2004; Quigley, 2006). In practice, glaucoma applies to all patients
with increased intraocular pressure (IOP) and/or glaucomatous damage (Flammer and Meier,
2003). In glaucoma, the nerve cells and nerve fibres progressively die, gradually severing
the connection between the eye and the brain. Since the rods and cones are still functioning,
the eye is able to detect the light, but the transmission of visual information to the brain is
interrupted. One of the most common types of glaucoma is primary open-angle glaucoma
(POAG). POAG is a chronic disease, tends to be inherited and may not show up until later
in life. There is no cure for it at present, but the disease can be slowed or arrested by
treatment. An increased IOP is an important risk factor for glaucoma, which can easily be
monitored and treated. However, because most people with glaucoma have no early symptoms
or pain from this increased pressure, it is often only detected once long-term visual loss has
occurred. Detecting glaucoma at an early stage is important in order to keep the damage
as small as possible, with little or no impact on the patient’s quality of life. Both structural
and functional tests are routinely used in clinical practice for diagnosis and monitoring of
glaucoma. Structural tests, provided by several imaging modalities, are objective, fast and
reliable. However, measurements obtained from these tests are largely influenced by the
variability of optic disc size and the number of nerve fibers among individuals. At present,
structural measurements can be used to diagnose early glaucoma, but cannot be used to
exclude it. Functional tests, such as perimetry, represent the most important clinical endpoint.
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However, perimetry is a subjective test and the results are prone to variability. Knowing
the sources of the variability might enable reducing it, and this may improve progression
detection in glaucoma. With less variability, smaller changes can be picked up and fewer tests
are needed. Although both tests are important, in this thesis we focus on the testing of visual
function using perimetry.
1.4 Visual Field Testing
Currently, the Humphrey Field Analyzer (HFA) (Carl Zeiss Meditec, Dublin, CA) is one
of the standards of care for glaucoma diagnosis and management. An illustration of the HFA
in use is shown in Figure 1.3. The patient sits in front of the device with a fixation target in the
center. The patient’s chin is rested and the eye that is not being tested is covered. Differential
light stimuli are then presented at predefined locations. The patient is required to press a
button whenever a light is seen. The light intensity and location are varied. This maps and
quantifies visual function. Using one of the default settings, the 24-2 program, this results
in a print-out of the VF with sensitivity estimates describing the threshold at each of the 52
locations. The maximum luminance of the Humphrey Field Analyzer perimeter’s stimuli is
10,000 abs, which is defined as 0 dB retinal sensitivity. The lowest sensitivity that can be
detected by this perimeter is therefore 0 dB, although lower sensitivities could in fact occur if
it were not for the limitations of this device. The highest sensitivity that can be detected is 50
dB (0.1 abs). Few humans are however capable of seeing a stimulus less than 40 dB, which
is 1/10,000 of the maximum (or 1 abs) (Anderson and Patella, 1999). Thus, for practical
purposes, the useful intensity range for white light testing is from 0 to 40 dB.
Figure 1.3: Illustration of the HFA in use.
A common approach to reduce measurement variability is to average multiple
measurements. Mean deviation (MD) expresses the overall reduction in sensitivity. This
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is averaged across the VF and is relative to a group of healthy age-matched subjects. The
visual field index (VFI) describes the visual function as a percentage of a perimetrically
normal age-corrected VF. It is an eccentricity-weighted mean of all the scores at all 52
locations (excluding the 2 corresponding to the blind spot), measured from 0 % (blind) to
100 % (normal). Modeling of individual VF points is potentially of greater interest, because
it provides additional information such as the spatial nature of the fields, that is otherwise lost
in global parameters.
1.5 Glaucoma Study
The Glaucoma Study is a prospective cohort study conducted by the Rotterdam Eye
Hospital in the Netherlands. This is an ongoing study which began in 1998. Inclusion
criteria included glaucoma diagnosis and an age range of 18 to 85 years. In total, 139
patients, consisting of 80 (57.6%) men and 59 (42.4%) women, were recruited with a mean
follow-up of 10.5 years. Follow-up data were collected at approximately 6-monthly intervals.
All patients gave their written informed consent for participation. All research procedures
followed the tenets set forth in the Declaration of Helsinki. Furthermore, all of the data that
was used in this analysis has been made available online at http://rod-rep.com.
1.6 Statistical Approach
Adequate treatment may slow down the disease, possibly even halting its progression.
Evaluation of a longitudinal series of visual fields (VF), as measured by standard automated
perimetry (SAP), provides a method to detect early evidence of glaucoma and to determine
functional deterioration. Hence, treatment strategies can then be optimized to prevent further
VF loss. Modelling the sensitivity estimates is beneficial for this evaluation. This helps to
extract the systematic part of the data and distinguish it from noise, tries to determine the
underlying VF progression from observed measurements, and can be used in the prediction of
future VFs.
From a statistical modeling viewpoint the analysis of the VF data presents several challenges.
First, VF testing involves measuring the level of differential light sensitivity at different
locations. The sensitivity estimates are left-censored due to the limitation of the device used
to measure them. Furthermore, the dataset in this study is clustered in nature. The hierarchical
structure of the data includes 4 levels, namely, (1) the individual, (2) the eye (3) the hemifield
and (4) the location. Correlation of VF measurements within the inferior and superior
hemifields, separated by the horizontal meridian, are assumed to be higher than between
hemifields due to the structure of the nerve fibres. Furthermore, observations belonging to
the same eye are expected to be more alike than observations drawn from an independent
eye. The same applies to observations from eyes belonging to the same individual. The
easiest but crude way of dealing with the complexity is to either ignore the clustering or
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simplify the data structure. For example, by using regression models treating each location
as an independent sample. However, this might lead to loss of information and possibility of
erroneous conclusions (Liang and Zeger, 1986; Molenberghs and Verbeke, 2005). Multilevel
models have been introduced to deal with the phenomenon of data nesting (Leyland and
Goldstein, 2001). Multilevel modeling is a generalization of regression methods whereby
random coefficients are introduced for each level in the data.
Another difficulty in modeling VF data is the amount and type of measurement error in
the sensitivity estimates. This may be due to measurable factors, such as season and time
of day, or unknown transient factors, such as fatigue or lack of concentration. Although
their magnitudes may vary, these factors are global and affect all locations belonging to the
same eye at each visit. In addition, there is an inverse relationship between sensitivity and
variability. For example, measurement error in the VFs increases with damage, and hence low
sensitivity estimates have high variability. Therefore, it is naive to assume a constant variance
over the wide range of sensitivity estimates.
1.7 Aims of this Thesis
The main aim of this thesis is to model this complex data structure in order to obtain
better estimates of the true evolution of the sensitivity over time. In order to achieve this we
need to deal with two main aspects of the data, namely, (1) time and (2) location. Our aim is
to build up a model to incorporate the aforementioned aspects by using a hierarchical model,
and to deal with the various sources of measurement error. In this way we can develop a
method for modeling the progression of glaucoma. Furthermore, we aim to investigate and
evaluate methods to improve the computational difficulties which arise for complex models
using standard methods.
1.8 Outline of this Thesis
An introduction to the statistical methods used in this thesis are described in Chapter 2.
Regression models are currently a standard method for modeling VF data. In Chapter 3, we
show a comparison of different regression models for the fitting and prediction of progression
in glaucomatous VFs. We apply classical approaches, as well as robust methods and models
which take into account censoring. A problem with regression models is that each location is
assumed to be independent. This ignores the correlation between measurements and does not
allow borrowing information from the whole dataset. To account for the complex structure
of the data, we apply advanced Bayesian hierarchical models in Chapter 4. Furthermore, we
apply a recently proposed two-stage approach which allows us to speed up computational
time considerably while still benefiting from the full Bayesian approach. In addition, we
extend this approach to allow the calculation of model selection and model evaluation criteria.
We investigate and compare other methods, such as integrated nested Laplace approximation
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(INLA) and hierarchical likelihood (H-likelihood) to the classical one-stage and two-stage
approaches in Chapter 5. For the clinical application, we propose to model factors which
affect all locations belonging to the same VF as global visit effects (GVEs). Details and an
evaluation of the GVE can be found in Chapter 6. Finally, in Chapter 7 we give the conclusions
and highlight the major findings and limitations of our research. We also suggest future work
related to this topic.
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2. Introduction to Statistical Methods
2.1 Mixed-Effects Models for Longitudinal Data
Longitudinal data are very common in applied sciences. Longitudinal studies involve
repeated measurements of the same variable for each individual in the study over a period
of time. Measurements from the same individual are likely to be more correlated than
measurements from different individuals. In practice, longitudinal data are often unbalanced,
meaning that individuals have an unequal number of measurements and/or that measurements
were taken at different points. Due to their unbalanced nature, many longitudinal data
sets cannot be analyzed by means of multivariate regression techniques (Verbeke and
Molenberghs, 2000). A standard modeling framework for the analysis of longitudinal
data, which deals with both the aforementioned issues, is the mixed-effects model. To
introduce these models, we let yi j denote the follow-up measurements for the i-th individual
(i= 1, . . . ,n) at time ti j where j denotes the specific time point j= 1, . . . ,ni. The mixed-effects
model can be written as
yi j = x>i jβ + z>i jbi + εi j,
bi ∼ N(0,Σb),
εi j ∼ N(0,σ2),
where β denotes the vector with the regression coefficients of the design matrix for the fixed
effects xi and zi denotes row vectors of the design matrix for the random effects bi. In
particular, the fixed and the random effects refer to the population-average and subject-specific
effects, respectively. Furthermore, Σb is the covariance-variance matrix of the random effects,
εi j are the error terms and σ2 is the variance of the error. Multilevel models deal with
nested data (Leyland and Goldstein, 2001). A mixed-effects model may also be viewed as
a multilevel or hierarchical model in which the level-1 observations are nested within the
higher level-2 observations. For example, in longitudinal studies repeated observations from
an individual are nested within this individual.
2.2 The frequentist approach to statistical inference
In the frequentist approach, the unknown parameter θ is considered fixed and inference
is done given observed data. A common way to estimate the model parameters is done using
maximum likelihood estimation (MLE). MLE determines the parameter estimates which
maximize the likelihood function, L(θ | y) = p(y | θ). For simple models without random
effects, the likelihood function can easily be written analytically. For mixed models containing
random effects, the marginal likelihood is calculated by integrating over the random effects to
obtain the MLEs.
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2.3 The Bayesian approach to statistical inference
The main difference between the frequentist and the Bayesian approach is that the latter
considers parameters as random variables that are characterized by a prior distribution. In the
Bayesian approach, θ is assumed to be a random variable with density function p(θ). The
prior distribution, which we denote as p(θ), represents the information about an uncertain
parameter (Lesaffre and Lawson, 2012). Prior information may be obtained from expert
knowledge, historical information, etc. In Bayesian inference, the prior distribution is
combined with the probability distribution of the new data to yield the posterior distribution,
given by:
p(θ | y) = L(θ | y)p(θ)∫
L(θ | y)p(θ)dθ .
For more extensive details on the methodology, as well as practical issues, of the Bayesian
approach we refer to (Lesaffre and Lawson, 2012).
2.3.1 Bayesian Computational Techniques
For complex models, the posterior distribution often cannot be determined analytically.
Calculating the integral by means of numerical integration methods is a practical alternative if
only a few parameters are involved, but it becomes difficult for real-life applications where the
dimensionality is often high (Lesaffre and Lawson, 2012). These problems can be avoided by
using sampling techniques yielding Markov chains. A popular class of sampling algorithms is
Markov chain Monte Carlo (MCMC) methods. The two most important MCMC procedures
are the Gibbs sampler and the Metropolis(-Hastings) algorithm.
2.3.1.1 Gibbs sampler
The Gibbs sampler, introduced by (Geman and Geman, 1984), uses the property that
the joint distribution is uniquely determined by its conditional distributions. In the Bayesian
context, this implies for two dimensions that p(θ1,θ2 | y) is uniquely determined by p(θ1 |
θ2,y) and p(θ2 | θ1,y). The Gibbs sampler explores the posterior distribution by generating
sampled values in a sequential manner. Given θ k1 and θ
k
2 at iteration k, the (k+ 1)-th value
for each of the parameters is generated according to an iterative scheme. For the general case
with d parameters:
• Set initial values θ01 ,θ02 , . . .θ0d
• Sample θ (k+1)1 from p(θ1 | θ k2 ,θ k3 , . . . ,θ k(d−1),θ kd ,y)
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• Sample θ (k+1)2 from p(θ2 | θ
(k+1)
1 ,θ
k
3 , . . . ,θ
k
d ,y)
• . . .
• Sample θ (k+1)d from p(θd | θ
(k+1)
1 , . . . ,θ
(k+1)
d−1 ,y)
Hence, the Gibbs sampler generates a Markov chain which constitutes a dependent sample
from the posterior distribution starting from a well chosen iteration (Lesaffre and Lawson,
2012).
2.3.1.2 Metropolis-Hastings algorithm
The Metropolis-Hastings (MH) algorithm is a general MCMC technique to sample from
the posterior distribution. In contrast to the Gibbs sampler, the MH algorithm does not require
the full conditionals (Lesaffre and Lawson, 2012). The d parameters θ are sampled from a
proposal distribution q. A portion of these samples will be accepted to yield a sample from the
posterior distribution p(θ | y). This approach samples all d parameters together, according to
the following iterative scheme:
• Set initial values θ0
• Sample θ˜ from the proposal density q(θ˜ | θ), with θ = θ k
• Calculate the acceptance ratio:
α(θ k, θ˜) = min
(
p(θ˜ | y)q(θ k | θ˜)
p(θ k | y)q(θ˜ | θ k) ,1
)
• Update θ (k+1) = θ˜ with probability α(θ k, θ˜); otherwise set θ (k+1) = θ k
2.3.1.3 Combination of Gibbs sampler and Metropolis-Hastings algorithm
Mathematically, the MH algorithm encompasses Gibbs sampling. The Gibbs sampler
is equivalent to the composition of d MH algorithms with acceptance probabilities all equal
to 1. Combinations of these two approaches are also possible. For example, by using a
Metropolis-within-Gibbs technique.
2.3.2 Software
Both Gibbs sampling and the Metropolis algorithm can be performed with software such
as Bayesian inference Using Gibbs Sampling (BUGS) (Lunn et al., 2009). WinBUGS is the
Windows version of the program BUGS and is one of the most popular software for Bayesian
analysis (Lunn et al., 2000). WinBUGS carries out Bayesian inference by means of MCMC
12
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methods. The whole program can be managed from R, using the R2WinBUGS package. This
allows the user to submit the data and model file to WinBUGS, batch processing the MCMC
sampling in WinBUGS and returning the samples to R for processing. OpenBUGS is an
open source version of WinBUGS that runs on MS Windows. OpenBUGS is very similar to
WinBUGS with regards to a lot of aspects. However, there is a greater class of algorithms
available in OpenBUGS, hence more flexibility when fitting complex models. Another
powerful software for Bayesian analysis using MCMC methods is JAGS (Just Another Gibbs
Sampler). JAGS was developed and is maintained by (Plummer, 2003). The main advantage
of JAGS over WinBUGS and OpenBUGS is its C++ platform hence can be written via
command prompts, while the BUGS family is written in Pascal which is only available for
Windows. The R packages R2jags and rjags can be used to manage the whole program
from R. Another important statistical software is SAS R©. SAS R© is a versatile package
of programs providing tools for setting up data bases, general data handling, statistical
programming, and statistical analyses. Two SAS R© procedures allow a Bayesian regression
analysis, namely, PROC GENMOD and PROC MCMC. Approaches such as integrated nested
Laplace approximations (INLA) and hierarchical likelihood (h-likelihood) provide alternative
options. INLA is based on sophisticated Laplace approximations (Rue and Martino, 2007;
Rue et al., 2009). Since no sampling is involved, computations appear to be much faster
than with MCMC algorithms while keeping a high precision on the posterior estimates of the
parameters. H-likelihood was developed by (Lee and Nelder, 1996) and provides a method to
model correlated data while avoiding the computation of the marginal likelihood. For a more
detailed comparison of software for Bayesian inference, we refer to Lesaffre and Lawson
(2012).
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Abstract
Purpose: Classical regression is based on certain assumptions that conflict with visual
field data. We investigate and evaluate different regression models and their assumptions
in order to determine point-wise visual field (VF) progression in glaucoma and to better
predict future field loss for personalised clinical glaucoma management. Methods: Standard
automated visual fields of 130 patients with primary glaucoma with a minimum of 6 years
of follow-up were included. Sensitivity estimates at each VF location were regressed on
time with classical linear and exponential regression models, as well as different variants
of these models that take into account censoring and allow robust fits. These models were
compared for the best fit and for their predictive ability. The prediction was evaluated at
6 measurements (about 3 years) ahead using varying numbers of measurements. Results:
For fitting the data, the classical uncensored linear regression model had the lowest root mean
square error and 95th percentile of the absolute errors. These errors were reduced in all models
when increasing the number of measurements used for the prediction of future measurements,
with the classical uncensored linear regression model having the lowest values for these errors
irrespective of how many measurements were included. Conclusion: All models performed
similarly. Despite violation of its assumptions, the classical uncensored linear regression
model appeared to provide the best fit for our data. In addition, this model appeared to
perform the best when predicting future visual fields. However, more advanced regression
models exploring any temporal-spatial relationships of glaucomatous progression are needed
to reduce prediction errors to clinically meaningful levels.
3.1 Introduction
According to the World Health Organisation (WHO), glaucoma is one of the leading
causes of blindness in the world. Adequate treatment may slow down the disease, possibly
even halting its progression (Kingman, 2004). Evaluation of a longitudinal series of visual
fields (VF), as measured by standard automated perimetry, provides a method to detect early
evidence of glaucoma and to determine functional deterioration (Flammer and Meier, 2003).
Hence, treatment strategies can then be optimized to prevent further progression of VF loss.
Modeling the series of VFs is beneficial for this evaluation. It tries to extract the underlying
VF progression from observed measurements and to distinguish it from noise, and can be used
in the prediction of future visual fields.
Longitudinal modeling of VF summary parameters, such as the mean deviation (MD)
and the visual field index (VFI), has been done before (Bengtsson and Heijl, 2008; Kymes
et al., 2012; Artes et al., 2011). Modeling of individual VF points is potentially of greater
interest, because it provides additional information such as the spatial nature of the fields,
that is otherwise lost in global parameters (Azarbod et al., 2012). Modeling the progression
of glaucoma in individual test locations may be of significant interest to best determine
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patterns of progression. For example, more centrally located progression would arguably be
of greater significance to the patient than more peripherally located progression. In addition,
if progression took place in a particular location of the VF that was also affected in the fellow
eye, this local progression would be more significant to the patients quality of life than when
the local progression took place elsewhere in the field, where no such overlapping defects
existed. Determining and predicting the pattern and location of progression would therefore
help clinicians to best tailor the management of glaucoma in their patients.
Caprioli et al. (2011) discussed measuring the rate of VF progression in glaucoma for
each VF location independently. They explored regression analysis of the sensitivity estimates
against time in three models: linear, quadratic, and non-linear exponential. There were some
aspects of VF data that were not taken into account in these models. Firstly, the maximum
luminance of the Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA) perimeters
stimuli is 10000 apostilbs, which is defined as 0 dB retinal sensitivity. The lowest sensitivity
that can be detected by this perimeter is therefore 0 dB, although negative values could in
fact occur if it were not for the limitations of this device (Anderson and Patella, 1999). It is
therefore of interest to use a model that takes censoring at 0 dB into account, as suggested by
Russell and Crabb (2011). We think that this is especially true for locations showing more
advanced disease progression, with high sensitivity estimates in the early follow-up period,
but a relatively large number of 0 dB sensitivity estimates towards the end of the follow-up
period. The Tobit model is used to estimate the relationship between variables when there
is either left- or right-censoring (or above- and below-censoring) in the dependent variable
(Tobin, 1958). Another consideration of regression analysis that deserves attention is that
classical least-squares fitting is based on certain assumptions about the measurement error,
which in fact may be violated. For example, measurement error in visual fields increases
with damage, and hence low sensitivity estimates have high variability. However, values
lower than zero cannot be measured. This inherent censoring introduces a positive bias at
low sensitivity estimates, which is made worse by the increased variability for low sensitivity
estimates (Russell et al., 2012). Another problem in regression analysis is that of outliers or
points that do not follow the general trend. As in most practical problems, visual field data
may have several outliers. Single outliers may be easily identified in diagnostic tests, but it is
generally more difficult to identify multiple outliers (Hawkins, 1980). Therefore, regression
analyses that are effective, even in the presence of multiple outliers, need to be considered
(Rousseeuw and Leroy, 1987), such as robust methods (Draper and Smith, 1998; Koenker,
2005).
In past research, the main aim has been to compare different statistical models to
determine the optimal fit for the VF data. However, the model with the best fit to the data
and the best model for prediction may not be the same. More complicated models may fit the
data better, but in general, simpler models predict better since they are less likely to over-fit
the data. This was illustrated by McNaught et al., who concluded that the best compromise
between fitting and predicting sensitivity estimates is the linear model (McNaught et al.,
1995). Since glaucoma is a progressive disease and the purpose of modeling the progression
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is to be able to evaluate future field loss in a clinical setting, the predictive ability of these
models is of importance. Our aim therefore was to introduce these censored and robust
regression models for the point-specific evolutions of the visual fields and to evaluate these
models, as well as their assumptions, for modeling and predicting point-wise glaucomatous
VF progression.
3.2 Methods
The analysis was performed on the VF data of both eyes of 130 individuals from an
ongoing study conducted at the Rotterdam Eye Hospital, The Netherlands. The inclusion
criteria were glaucoma and a minimum of 15 VFs resulting in a minimum of 6 years of
follow-up; the first 15 VFs were used in our analyses. This group consisted of 72 (55%) men
and 58 (45%) women. All patients gave their written informed consent for participation. All
research procedures followed the tenets set forth in the Declaration of Helsinki. The patients
were followed up approximately twice per year. The data set contained 3900 VFs, resulting
in time series of 13520 VF points. Descriptive statistics can be found in Table 3.1. All of the
data that was used in this study has been made available online at http://orgids.com.
Table 3.1: Descriptive statistics of the study sample
Mean Median Interquartile Range
Baseline age (years) 59.8 61.4 53.3 ; 67.6
Baseline MD (dB) -8.3 -5.8 -12.8 ; -2.3
Average change in MD (dB/year) -0.07 -0.04 -0.2; 0.1
Follow-up time (years) 7.7 7.6 7.2 ; 8.2
The VFs were tested by using the Humphrey Field Analyzer with the 24-2, white-on-white
test strategy using the Full Threshold algorithm. The response variables of interest were the
sensitivity estimates from the 52 VF points (excluding the 2 points that correspond to the
blind spot). These locations were analysed as independent samples. The distribution of the
observed sensitivity estimates is shown in Figure 3.1. Note that the frequency of points with
0 dB sensitivity was relatively large, which emphasizes the need to specifically address these
measurements.
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Figure 3.1: Distribution of point-wise sensitivity estimates in the study dataset.
An example of the series of VFs for one eye of a patient can be seen in Figure 3.2, which
shows the sensitivity estimates for each location in the VF over a period of 9 years. This
example clearly shows little or no progressive damage with little measurement variability in
the superior hemifield and markedly progressive changes with relatively large measurement
variability in most points of the inferior hemifield. There is also significant measurement
variability in the upper, most nasal point of the upper hemifield.
3.2.1 Models
Regression models estimate the relationship between variables. The most straightforward
approach is the linear regression model, which minimizes the sum of squared deviations from
the regression line and passes through the mean in a straight line. A non-linear alternative is
the exponential model. The 2 corresponding statistical models are:
1. First-order linear: yi = a+bxi + εi
2. First-order exponential: yi = ea+bxi + εi
where denotes in our current study an index that is unique for every VF location in
each eye (i= 1, . . . ,13520), yi is the measured sensitivity estimate expressed in dB, xi denotes
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Figure 3.2: Retinal sensitivity estimates over time for each position of the visual field in the left eye of a
single glaucoma patient.
the time the VF was acquired, a and b are the model parameters to be estimated and ε is the
error term. Here, we assume that the error term is independently and identically normally
distributed with a mean of zero and variance σ2, i.e. εi ∼ N(0,σ2).
A censored (Tobit) model in our current analysis takes into account that unseen sensitivity
estimates that are indicated on the VF print out as < 0 do not correspond to true zero values:
they are smaller than zero but the instrument was unable to determine such sensitivities. The
model thus tries to estimate the relationship between time and the latent, true sensitivity
value. The relationship between the observed and the latent, true sensitivity value is given by
y∗ = y× I(y≥ 0) + 0× I(y< 0).
Censoring was here taken into account for the linear model only. The response variable of
the exponential model cannot go below 0 dB. Therefore, taking censoring at 0 dB into account
in the model will not gain anything.
Linear and exponential models for the median, so-called median regression models were
also included. Median regression provides a line which minimizes the sum of absolute
values of the deviations from the regression line. Quantile regression, which includes median
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regression, provides a method that is less influenced by extreme values. Median regression
models can estimate the true rate of change even in cases where a significant fraction of the
measurements has large errors. Other robust methods might be considered such as Least
Absolute Deviations Regression (Edgeworth, 1887), M-estimators (Huber, 1981), and Robust
Regression with Ranked Residuals (Draper and Smith, 1998), however including all these
models would be beyond the scope of this paper (Hoaglin et al., 1981).
We evaluated the following 6 models: the classical uncensored linear model, the classical
exponential model, the classical censored linear model, the uncensored linear on the median
model, the exponential on the median model, and the censored linear on the median model.
Examples of some of the fits are shown in Figure 3.3. The points represent the sensitivity
estimates from two locations belonging to the same eye from our data set, and the lines show
the fits of the models based on this data. The left frame shows a case in which it is useful to
take the censored nature of the data into account. The classical censored linear model takes
into account that the measurements are censored at 0 dB, and hence shows the best model
fit. This is only beneficial when there is progression, resulting in many 0 dB measurements.
The right frame is an example which shows the need for more robust methods such as median
regression. Here it is clear that the uncensored linear on the median fit is less influenced by
the outlying points, notably during the first 2 years of follow-up, than the other models. These
2 examples show that it is not a priori obvious which model best fits the observed point-wise
VF data.
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Figure 3.3: Two real examples of sensitivity estimates over time at 2 single location in the visual field.
The lines indicate corresponding fits of 4 models.
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3.2.2 Truncating the Predicted Response
Conventional models are designed to fit observed data, while censored models are
designed to fit the true but unobserved data. To be able to compare predicted values from all
models, the predicted values calculated to be less than 0 dB were set to 0 dB for the evaluation
of both the fitting and the prediction of the data. Likewise, since the measured sensitivity
estimates cannot realistically be above 40 dB, this limit was also set on the predicted values
(Anderson and Patella, 1999).
3.2.3 Evaluation of model fit
We employed 2 classical approaches for the overall predictive ability of the models. The
first aimed to measure how close the predicted values were to the observed responses in
the current data (ie. model fit). This may be done using the Akaike Information Criterion
(AIC). AIC is defined as 2k− 2ln(L), where k is the number of model parameters and L is
the likelihood function evaluated at the estimated parameter values (Akaike, 1981). −2ln(L)
measures the model fit to the current data. By adding the model complexity indicated by 2k,
complex models are penalized. Generally, AIC is used to compare non-nested models with the
same response, such as the classical uncensored linear and the classical exponential model.
However, if the responses differ, one should compare AIC values with caution. In the case
when comparing uncensored and censored models, it is not clear whether AIC can be used.
An alternative to the AIC is leave-one-out cross-validation. We combined the errors (given
by the predicted minus the observed sensitivity estimate) from each sensitivity estimate into
summary error measures and compared the root mean square error (RMSE) and the mean
absolute error (MAE) for each of the models. We compared both the RMSE and MAE
since, by definition, the classical regression models minimize the RMSE while the median
regression models minimize the MAE. We evaluated only the classical uncensored linear and
classical exponential models by means of AIC, ranking them by percentage of best fits in
order to compare our results to previous work (Caprioli et al., 2011), but used leave-one-out
cross-validation to calculate the RMSE and MAE for the comparison of all models.
In clinical practice, one is primarily interested in VFs of individual eyes. Hence, interest lies
in having a large fraction of patients within an estimated range, rather than looking at the
average error over all eyes. Therefore we also computed the 95th percentile of the absolute
errors, which is the value below which 95% of the absolute prediction errors may be found,
to compare all models.
Since the RMSE and MAE were evaluated as summary measures, these statistics conceal
how the models performed at the different levels of the sensitivities. Hence, to evaluate the
models in greater detail, we also stratified the MAE over the range of sensitivity estimates to
determine how the models perform at different sensitivity levels. In order to further investigate
whether the assumptions that are made by the classical regression models hold, we evaluated
the whole error distribution over the range of sensitivity estimates.
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3.2.4 Evaluation of predictive ability
The second approach aimed to measure how each model performed with respect to
predicting future measurements. This involves using the first sequence of data to estimate the
model parameters and calculate a future measurement value for that point in the VF. This was
done by varying the number of measurements used for the estimation, each time predicting
the sensitivity estimates 6 measurements (approximately 3 years) ahead. All the models were
evaluated by using the RMSE, MAE and 95th percentile of the absolute errors. As done
for the comparison of the models fitting abilities, the MAEs were stratified over the range
of sensitivity estimates to compare the models predictive abilities at the different sensitivity
levels.
3.3 Results
3.3.1 Evaluation of model fit
When ranking the classical uncensored linear and the classical exponential models based
on AIC, the classical uncensored linear model performed best in 57% of the fits, while the
classical exponential model had 43% of the best fits. The RMSE, MAE and 95th percentile of
the absolute errors for all models, calculated by cross-validation, are listed in Table 3.2. On
our dataset, the classical censored linear model had the lowest MAE, although the MAE was
almost the same over all the models. The classical uncensored linear model had the lowest
RMSE and 95th percentile of the absolute error. All the models performed similarly. Overall,
however, the classical uncensored linear model appeared to be the best model for our data.
Table 3.2: Comparison of the fitting ability of the models for the predicted values
Model RMSE (dB) MAE (dB) 95th Percentile (dB)
Classical Uncensored Linear 3.65 2.37 7.93
Classical Exponential 3.77 2.39 8.02
Classical Censored Linear 3.72 2.33 8.09
Uncensored Linear on the Median 3.81 2.34 8.26
Exponential on the Median 3.93 2.37 8.41
Censored Linear on the Median 3.83 2.34 8.31
Figure 3.4 shows the fitting ability of the models over different sensitivity levels. This
shows a clear trend throughout the models, with low MAEs at 0 dB and in the range from 20
dB to 35 dB. This corresponds to the most frequently observed sensitivity estimates, as shown
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in Figure 3.1. The models perform the worst between 0 dB and 25 dB and above 35 dB, where
there are very few measurements and hence the models are not being optimized very well at
these high sensitivity levels.
Figure 3.4: Mean absolute error from cross validation to evaluate the fitting ability of each model divided
over the range of observed sensitivity estimates.
As a further step, we investigated the error distribution across the entire sensitivity range.
Since the models all performed similarly, this was only done for the classical uncensored
linear model, which had been found to be the best model. Curves of the 10th, 25th, 50th, 75th
and 90th percentiles of the error are plotted for this model in Figure 3.5, superimposed over
a smoothed scatter plot showing the observed sensitivity estimates versus the corresponding
errors. The median of the errors approximated to zero for sensitivities around 0 dB and 25
dB. From 30 dB down to 10 dB, the median remained close to zero, but the whole distribution
became wider. However, from 10 dB down to 0 dB the magnitude of the negative errors
decreased due to the truncation at the range, while it continued increasing for the positive
errors.
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Figure 3.5: Smoothed scatter plot of the observed sensitivity estimates versus the corresponding error
from cross validation including percentile curves (10th, 25th, 50th, 75th and 90th) across the range of
sensitivity levels for classical uncensored linear regression. The dark blue areas correspond to a high
density of observed sensitivity estimates.
3.3.2 Evaluation of predictive ability
For 3-year predictions, RMSE, MAE and 95th percentiles of the absolute errors were
estimated for all models. The results are presented in Table 3.3. The classical uncensored
linear model had the lowest RMSE, MAE and 95th percentile of the absolute errors. Since the
variations from the classical uncensored models all performed worse than classical uncensored
models, we have included only the results for the classical uncensored linear and classical
exponential regression models in Figure 3.6. Here the MAE and 95th percentiles of the
absolute errors for 3-year-predictions have been shown graphically for a varying numbers
of time points. When including more measurements, the error was reduced; however the
ordering of the models did not change. The classical uncensored linear regression model
performed the best when comparing all the models irrespective of how many time points were
used.
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Table 3.3: Comparison of the predictive ability of the models by using 9 measurements to predict three
years (6 measurements) ahead
Model RMSE (dB) MAE (dB) 95th Percentile (dB)
Classical Uncensored Linear 6.02 3.95 13.13
Classical Exponential 7.29 4.39 15.00
Classical Censored Linear 6.34 4.05 14.00
Uncensored Linear on the Median 6.34 4.06 14.00
Exponential on the Median 7.58 4.49 16.20
Censored Linear on the Median 6.51 4.12 14.22
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Figure 3.6: Mean absolute and 95th percentiles of 3-year prediction errors for the classical uncensored
linear (black) and classical exponential (red) regression models.
Figure 3.7 shows the MAE over the range of sensitivity estimates when using 9
measurements to predict 3 years ahead. A similar trend could be seen throughout all the
models as found when comparing the model fits, with the lowest MAEs occurring at 0 dB and
between 25 dB and 35 dB. The difference between the models was however more pronounced
between 0 dB and 20 dB when predicting than it was when fitting the data. When predicting,
the exponential models were more likely to diverge and hence perform the worst within this
range.
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Figure 3.7: Mean absolute error to evaluate the predictive ability of each model divided over the range of
observed sensitivity estimates. * MAE ranges from 32.8 dB to 37.0 dB for the different models.
3.4 Discussion
When ranking the classical uncensored linear and classical exponential models, the
classical uncensored linear regression model was found to have the best fit most frequently
(57% versus 43%). These results differ from those obtained by Caprioli et al. (2011), who
concluded that the classical exponential model provided the best fit for their data in a very
large majority of cases. This could be due to different implementation of the models. Caprioli
et al. specified a mathematical model and not a statistical model. In the latter model it is also
specified how the error term enters the model (i.e. as an additive term to the exponential or
behind the exponential sign). Without knowing the statistical model which they used, we are
unable to determine whether our implementations were the same.
When including all the models, the MAEs were similar, and the classical uncensored
linear model again performed the best when comparing the RMSE and 95th percentile of
the absolute error. The classical uncensored linear regression model was also found to be
the best model for prediction irrespective of how many measurements were used to fit the
model. Although the models performed similarly, we conclude that for both fitting purposes,
i.e., for determining the rate of progression per test location, and for prediction of future
measurements, the classical uncensored linear regression model is recommended. However,
even for this model the mean absolute errors were still on the order of 2 dB for fitting, and 4
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dB for prediction, which is arguably too high to be of direct clinical use.
A possible reason for the poor discrimination between the goodness of fit of the various
fitting and predictive models is the low progression rates found in this study. This might be
due to having a younger cohort than other studies, different inclusion and exclusion criteria,
or the fairly large proportion of data points with 0 dB retinal sensitivity.
The lowest error for fitting the data was found to be at 0 dB and around 30 dB for all
models. This corresponds to the sensitivity estimates which were most frequently seen in this
dataset. In the same way, only a few measurements were seen between 0 dB and 25 dB and
above 35 dB, where the models all performed the worst. This is also the case when comparing
the predictive abilities of the models. It has also been shown that the test-retest variability is
highest in this range and hence the values which we assume to be true also have a high error
(Russell et al., 2012). However, the difference between the models was more evident between
0 dB and 20 dB when comparing the models for best predictive ability than for best fitting
ability. Hence, none of the models were being optimized well in this range, and the result of
this problem is even more evident when predicting future measurements. As before, the real
value of the sensitivity estimate is unknown. Therefore the measurements being predicted
also have error, so an accurate prediction of this measurement is not possible.
The distribution of the residuals was not symmetric and differed over the range of
sensitivity estimates, which is a violation of the assumption made by the classical regression
models. The bias towards negative errors was however emphasized at the higher end of the
range due to there being only a few measurements above 35 dB. The truncation of the negative
errors at the lower end of the range was due to the device not being able to measure sensitivity
estimates below zero, as well as the truncation of the predicted response which we applied in
our analysis. This could be an interesting aspect of the data to investigate further, by using a
model which assumes that the distribution of the residuals differ across the range of sensitivity
estimates.
In previous research, a quadratic model was often considered in addition to linear and
exponential models. Compared to linear and exponential models, these studies did not identify
the quadratic model as an improvement (Caprioli et al., 2011; McNaught et al., 1995). In
addition, the model is not monotonic and there are no theoretical reasons, e.g. from anatomy
or functional models, for using such a quadratic model. We also evaluated the quadratic model
but found no indication of its suitability in our application. We therefore argue that this model
can safely be excluded in future research on modeling time series of threshold sensitivities.
In this study, censoring was done at 0 dB as suggested by Russell and Crabb (2011).
However, recent research found that ganglion saturation can also account for high test-retest
variability between 0 dB and 25 dB and hence 0 dB is outside the dynamic range of a
ganglion cell (Swanson et al., 2011), and that sensitivities below 10 dB are mainly noise
(Junoy Montolio et al., 2012b). For this reason, we also considered censoring and truncating
of the predicted response at 10 dB. When censoring and truncation were done at 10 dB rather
than 0 dB, the MAE was higher for all the models, however the classical uncensored linear
model was still found to be the best model for fitting and for prediction.
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For future work, certain aspects of the data need to be further investigated. One of the
difficulties in modeling this data is the amount and type of measurement error and variability
in the sensitivity estimates. This may be due to blinking, eye movements, flagging attention
by the patient, fatigue, inexperience, a delayed reaction time and the patient forgetting to
press the button. Factors such as test reliability, technical experience, time of day and season
have been shown to influence standard automated perimetry test results (Junoy Montolio et al.,
2012). In order to measure the true progression of the disease, the high, sensitivity-dependent,
variability would need to be taken into account by incorporating it into the statistical model, or
new, more reproducible methods for determining the visual fields need to be developed. The
device should flag measurements if they fall outside a clinically acceptable range determined
from previous observations. This would indicate that either the measurement is wrong and the
test should be redone, or that there is a real change in the rate of progression and the treatment
strategy may need to be adjusted.
In addition, one could exploit the spatial nature of the data and capitalize on the specific
spatial organization of the nerve fibres in the eye (Denniss et al., 2012; Airaksinen et al., 2008).
A problem with using regression models is that each location is treated as an independent
sample and we are not able to link locations belonging to the same eye together. This problem
can be addressed by using spatial models or mixed-effects models which we propose for future
work (Verbeke and Molenberghs, 2000).
Finally, sensitivity estimates at different test locations in the same VF do not all progress
at the same speed, and directly modeling summary parameters will not be able to handle this
well. Hence it may also be interesting to compare the summary predictions by modeling the
MD directly and by predicting each point and consequently calculating the MD. This would
elucidate whether modeling the individual points is more informative than modeling global
indices (Azarbod et al., 2012).
In conclusion, we have shown that the classical uncensored linear model was found to
be the best model for fitting visual field data, as well as for predicting future visual field
measurements. However, despite the various theoretical pros and cons of each of the explored
models, none of them performed satisfactorily well, neither for fitting, nor for predicting
future damage, which is why we need to further explore models that take spatio-temporal
relationships more into consideration. Modeling point-wise threshold sensitivity over time is
relevant, but more advanced models are needed to further reduce prediction errors and produce
clinically meaningful results.
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Abstract
The Bayesian approach has become increasingly popular because it allows to fit quite
complex models to data via Markov chain Monte Carlo (MCMC) sampling. However, it
is also recognized nowadays that MCMC sampling can become computationally prohibitive
when applied to a large data set. We encountered serious computational difficulties when
fitting an hierarchical model to longitudinal glaucoma data of patients who participate in an
ongoing Dutch study. To overcome this problem, we applied and extended a recently proposed
two-stage approach to model these data. Glaucoma is one of the leading causes of blindness
in the world. In order to detect deterioration at an early stage, a model for predicting visual
fields (VF) in time is needed. Hence, the true underlying VF progression can be determined,
and treatment strategies can then be optimized to prevent further VF loss. Since we were
unable to fit these data with the classical one-stage approach upon which the current popular
Bayesian software is based, we made use of the two-stage Bayesian approach. The considered
hierarchical longitudinal model involves estimating a large number of random effects and
deals with censoring and high measurement variability. In addition, we extended the approach
with tools for model evaluation.
4.1 Introduction
Since the introduction of MCMC sampling by Gelfand and Smith (Gelfand and Smith,
1990) and the development of the BUGS software (Lunn et al., 2009) the Bayesian approach
has become tremendously popular in various application areas, but especially to fit models
to complex data structures. But with the years it also became clear that MCMC sampling
can be computationally quite cumbersome, and even prohibitive, for fitting complex models
to relatively large data sets. Several attempts have been made to look for alternative
computational procedures and software, with notable examples such as INLA (Rue et al.,
2009) and STAN (Hoffman and Gelman, 2014). While this newly developed software can
sometimes speed up the computations considerably, the computational gain is not always
obvious upfront and for some advanced models the new developments may not be suitable
yet. In addition, the majority of the practical Bayesians still use BUGS-related software. In
this context, Lunn et al. (2013) proposed to fit a hierarchical model in two stages. The authors
claim more model flexibility in this way, but advocate the use of their procedure especially
for its computational properties. In this paper we further illustrate the use of the two-stage
approach on a far more complex hierarchical data structure of glaucoma patients. In addition,
we extend the approach with an additional sampling step to allow the calculation of model
selection and model evaluation criteria.
Our modeling approach is motivated by data from the Glaucoma study conducted by the
Rotterdam Eye Hospital in the Netherlands. According to the World Health Organization
(WHO), glaucoma is one of the leading causes of irreversible blindness in the world
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(Kingman, 2004). Adequate treatment may slow down the disease, possibly even halting
its progression. Evaluation of a longitudinal series of visual fields (VF), as measured by
standard automated perimetry (SAP), provides a way to detect early evidence of glaucoma and
to determine functional deterioration. However, due to the subjective nature of this technique,
SAP is prone to large variability. In order to measure the true progression of the disease, this
variability needs to be taken into account. The Glaucoma study provides a unique database
with a long follow up time. Although statistical methods may have existed to model such data,
the difficulties in extracting it from the device has made this type of data rare and hence has
prevented much research on the topic.
The response variable of interest is the sensitivity estimate describing the level of
differential light sensitivity at different locations within each eye. The sensitivity estimates
are left-censored due to a limitation of the device. Models which take into account this type of
censoring, such as the Tobit model, have been described in the literature (Tobin, 1958). Our
interest lies in modeling the latent, true values rather than the observed sensitivity estimates
for two reasons. Firstly, clinical interest lies in predicting the disease progression rather
than the observed sensitivity estimates. Secondly, using the latent scale allows us to use a
simpler model than when directly modeling the observed data. The hierarchical structure of
the data consists of 4 levels, namely, (1) the individual, (2) the eye, (3) the hemifield and (4)
the location. There is a vast amount of literature that addresses hierarchical mixed-effects
models, for both frequentist (Verbeke and Molenberghs, 2000) and Bayesian (Ntzoufras,
2009; Lesaffre and Lawson, 2012) approaches. We model this complex data structure by
means of a Bayesian hierarchical mixed-effects model with cross-classified random effects.
Hence, we combine both spatial and time effects. One of the difficulties in modeling VF data is
the amount and type of measurement error or variability in the sensitivity estimates. This may
be due to measurable factors, such as season, time of day and reliability indices, or unknown
transient factors, such as fatigue, lack of concentration, or delayed reaction time. Although
their magnitudes may vary, these factors affect all locations belonging to the same VF. We
propose to model them as Global Visit Effects (GVEs). Furthermore, there is an inverse
relationship between sensitivity and variability. For example, measurement error in the VFs
increases with damage, and hence low sensitivity estimates have high variability. Therefore,
it is naive to assume a constant variance over the wide range of sensitivity estimates. In this
paper, we relax this assumption in order to incorporate this relationship. A problem with
high dimensional data and complex data structures, is that it is sometimes difficult or even
impossible to model them with standard MCMC algorithms. Lunn et al. (2013) proposed a
two-stage approach, which allowed us to simplify the problem while still benefiting from the
advantages of a full Bayesian model. However, one of the disadvantages of this approach,
is that it is not possible to directly obtain the random effects estimates needed for most
model comparisons. We address this issue by extending the two-stage approach to be able
to determine these estimates.
Our aim is to model this complex data structure in order to obtain better estimates of the
true evolution of the sensitivity over time, so that treatment strategies can be optimized to
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prevent further progression of VF loss. The structure of the paper is as follows. In Section
5.4.1 we give further details on the motivating data set and introduce the research questions
that triggered our modeling approach(es). In Section 5.2 we describe the models used in the
analysis. In the subsequent section we briefly review computational aspects of the analysis.
Model comparison is dealt with in Section 4.5. In Section 4.6 we apply our models to the
Glaucoma study data. Section 4.7 contains a concluding discussion. Further details regarding
the modeling approach are provided in an appendix.
4.2 Motivating data set: the Glaucoma study
4.2.1 Description of the project
The Glaucoma study is a prospective cohort study conducted by the Rotterdam Eye
Hospital in the Netherlands. This is an ongoing study which began in 1998. Inclusion
criteria included glaucoma diagnosis and an age range of 18 to 85 years. In total, 139
patients, consisting of 80 (57.6%) men and 59 (42.4%) women, were recruited with a mean
follow-up of 10.5 years. Note that for the statistical analysis of the data, we excluded one
patient (see Section 4.6) leading to N = 138 patients. Follow-up data were collected at
approximately 6-monthly intervals. All patients gave their written informed consent for
participation. All research procedures followed the tenets set forth in the Declaration of
Helsinki. Furthermore, all of the data that was used in this analysis has been made available
online at http://rod-rep.com.
Sensitivity estimates were measured at 52 test locations within each eye, or 26 test
locations within each hemifield (excluding two locations corresponding to the blind spot)
as shown in Figure 4.1. The VFs were tested using the Humphrey Field Analyzer with the
24-2, white-on-white test strategy using the Full Threshold algorithm. The light source can
be attenuated in the range from 1 to 10,000 times. On the decibel (dB) scale an attenuation
x is defined as s = 10 log10(x), or x = 10
s/10. The lowest sensitivity that can be detected
by this perimeter is 0 dB, although negative values could in fact occur if it were not for the
limitations of this device. The highest sensitivity that can be detected is 50 dB, however few
humans are capable of seeing a stimulus less than 40 dB, which is 1/10,000 of the maximum
intensity of the instrument (or 1 asb). Thus, for practical purposes, the useful intensity range
for white light testing is from 0 to 40 dB with a background illumination of 31.5 apostilb
(asb.) (Anderson and Patella, 1999).
4.2.2 Previous research
Parameters such as the mean deviation (MD) and visual field index (VFI) summarize the
52 sensitivity estimates into single values which can be used by the clinicians when optimizing
treatment strategies. Longitudinal modeling of these VF summary parameters has been done
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Figure 4.1: Fundus photo of a left human eye with the 54 test locations for the VF test represented by
white dots.
before (Bengtsson and Heijl, 2008; Artes et al., 2005; Kymes et al., 2012; Junoy Montolio
et al., 2012). Modeling of individual test locations is potentially of greater interest, because
it provides additional information such as the spatial nature of the fields which is otherwise
lost in global parameters. In previous research, each location was analyzed as an independent
sample (McNaught et al., 1995; Caprioli et al., 2011; Bryan et al., 2013). However, separate
location-specific regression models are not able to use any information from the data set
as a whole. Multilevel mixed-effects models provide a better fit to the data than separate
regression models by accounting for group effects and/or within-group correlation (Verbeke
and Molenberghs, 2000). This was shown in the context of global VF measurements by Pathak
et al. (2013).
In glaucoma, variability is presumably related to fatigue effects and response errors,
whereby sensitivity estimates decrease over time (Hudson et al., 1994; Bengtsson and
Heijl, 2000). Differences in fatigue effects, between the inferior and superior hemifields
within an eye have been demonstrated (Hudson et al., 1994). Furthermore, this effect may
differ between the first and second eye at the same visit. The number of false-negative
answers has been shown to be higher in eyes with field loss. This may be explained by
an increased variability in sensitivity estimates typically found in such eyes (Bengtsson and
Heijl, 2000; Russell et al., 2012). A common approach to reduce measurement variability is
to average multiple measurements. For example, random uncorrelated measurement errors
that are present in the point-wise sensitivity estimates are reduced when calculating summary
parameters such as the mean deviation (MD). Other errors, however, are spatially correlated
and affect the whole VF. One group of such errors are measurable factors, including season,
time of day and reliability indices, which have been evaluated before (Junoy Montolio et al.,
2012). Although the effects of these factors are statistically significant, they are rather small
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and hence only explain a small part of the observed global variation in VFs.
The inverse relationship between variability and sensitivity has been described in the
literature. Henson et al. (2000) found that this relationship is well represented by the function
ln(SD) = A+B× sensitivity(dB), where A and B are 2.81 dB and -0.066 dB respectively for
normal eyes and 3.62 dB and -0.098 dB for glaucomatous eyes. Russell et al. (2012) showed
that the distribution of residuals is relatively concentrated at high VF sensitivities (26 to 36 dB)
but stretches substantially as the sensitivity estimates decrease to a level of 10 dB. Sensitivity
estimates near 10 dB are associated with residuals spanning almost the entire dynamic range
of the instrument. This could be caused by a loss of ganglion cells (due to glaucomatous
damage), or relocation of the stimulus to the peripheral visual field where there are fewer
ganglion cells Swanson et al. (2011). Zhu et al. (2014) describe a method to detect change by
means of an inferential statistical model which incorporates the non-stationary variability and
uses a mixture of Weibull distributions.
Although there is a wide range of literature which discusses these aspects, the majority of
previous work deals with the global indices or treats sensitivity estimates for each location in
the VF as an independent sample. Furthermore, these aspects have been addressed separately.
Hence, it is clear that an approach which takes into account the complex structure of the data
and considers all of the aforementioned problems, is needed. We will address censoring, the
hierarchical structure, the global variation as well as the relationship between the variability
and sensitivity.
4.3 Statistical Models
Modeling the sensitivity estimates is beneficial for the evaluation of the progression of VF
loss. By incorporating biological effects into the model, we aimed to improve the model fit
and hence provide a better method for modeling this progression. This was done by building
the model up sequentially, resulting in 3 different proposed models.
4.3.1 Censoring
It is important to note that unseen sensitivity estimates are indicated on the VF print
out as < 0. They are smaller than zero because the instrument is unable to determine such
sensitivities. Thus a model which defines the relationship between time and the latent, true
sensitivity estimate is needed. The relationship between the observed sensitivity estimate y
and the latent, true sensitivity estimate y∗ is given by y = max(0,y∗).
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4.3.2 Hierarchical model
We propose using a Bayesian hierarchical mixed-effects model (Ntzoufras, 2009;
Lesaffre and Lawson, 2012) to analyze the glaucoma data. This model is able to take into
account both the within subject and between subject variability. Furthermore, we capitalized
on the common features within each eye by taking into account the correlation between
measurements belonging to the same eye. In addition, correlation of VF measurements
within the inferior and superior hemifields, separated by the horizontal raphe, was assumed
to be higher than between hemifields. Hence, the hierarchical structure of the data consists of
4 levels, namely, (1) the individual, (2) the eye, (3) the hemifield and (4) the location. The
dependent variable in the model is y∗iehlt , which denotes the latent sensitivity estimate for
individual i = 1, . . . ,N; eye e = 1,2; hemifield h = 1,2 and location l = 1, . . . ,26 at timepoint
t = 1, . . . ,Ti. The independent variable in the model is timeit , which represents the time (in
years) between tth measurement and the first measurement for each individual i, ranging
from 0 to 10.5 years. Let µα = (µα0 ,µα1)T correspond to the population-averaged intercept
and slope of time. The individual-specific intercept and slope of time for individual i are
represented by α0i and α1i, with deviations due to the eye given by γ0ie and γ1ie, due to the
hemifield by η0ieh and η1ieh, and due to the location by λ0iehl and λ1iehl . We call this Model 1.
Model 1:
y∗iehlt = α0i +α1itimeit + γ0ie + γ1ietimeit +η0ieh +η1iehtimeit +λ0iehl +
λ1iehl timeit + εiehlt (4.3.1)
= µ(1)iehlt + εiehlt ,
where εiehlt ∼ N(0,σ2ε ) and with priors:
αi =
(α0i
α1i
)∼ N((µα0µα1 ) ,Σα) ;
γie =
( γ0ie
γ1ie
)∼ N((00) ,Σγ );
ηieh =
(η0ieh
η1ieh
)∼ N((00),Ση );
λiehl =
(
λ0iehl
λ1iehl
)
∼ N((00) ,Σλ );
µαb ∼ N(0,109) for b = 0,1;
σ2ε ∼ IG(10−3,10−3);
Σα ,Σγ ,Ση and Σλ ∼ IW(diag(1,1),2).
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4.3.3 Global Visit Effect
Junoy Montolio et al. (2012) explicitly modeled the global variations with known
factors such as season, time of day and reliability indices. However, we speculated that other
transient factors, such as fatigue, lack of concentration, or delayed reaction time may play
a more important role. Since all these (as well as possibly other) factors affect all locations
belonging to the same VF, we propose to take them together and to call them, as well as
model them as the Global Visit Effects (GVEs). In this way, we can account for both the
known and the unknown factors. Hence, the GVE accounts for all factors that affect all
measurements of the same eye at each visit. The GVE is an eye-specific visit effect. The
term “global” relates to the whole VF. To illustrate the importance of these factors, we show
in Figure 4.12 the VFs over time of one eye, where all locations have a drastic decrease in
sensitivity at around one year. From the longitudinal profiles, it is evident that this decrease
is caused by something that affected all VF measurements of that visit, rather than by actual
damage. To account for the visit-dependent offset at all locations, or GVE, we included a
parameter, φiet , in the following model to capture the offset at the tth time point for eye e
within individual i. This gives Model 2.
Model 2:
y∗iehlt = µ
(2)
iehlt + εiehlt
= µ(1)iehlt +φiet + εiehlt (4.3.2)
From an initial exploratory analysis, we observed a number of spikes in the distribution
of the visit effects. To accommodate these spikes, we assumed a t-distribution for φiet . The
t-distribution allows greater flexibility in the distribution of random effects compared to the
normal distribution, and can handle heavy tails (Lee and Thompson, 2008). Hence, we let
φiet ∼ t(0,σ2φ ,3),
where t(µ,σ2,d f ) denotes the generalized t-distribution with mean µ , scale parameter σ2,
and d f degrees of freedom. The prior for σ2φ was taken equal to IG(10
−3,10−3).
4.3.4 Relationship between variability and sensitivity
There is an association between a decline in VF sensitivity and an increase in response
variability. However, values lower than 0 dB cannot be measured. This inherent censoring
process introduces a positive bias at low sensitivity estimates, which is made worse by
the increased variability for low sensitivity estimates. We assumed a linear relationship
between the expected values of the sensitivity estimates and the logarithm of the standard
deviation. However, since we were interested in modeling the latent sensitivity estimates, we
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Figure 4.2: Retinal sensitivity estimates over time for each location of the visual field in the left eye of
a single glaucoma patient. A decrease in the sensitivity estimates can be seen in all locations at around
1 year. The longitudinal profile of the MD values over time is shown on the right. The visit-dependent
decrease is also clear at around 1 year for the MD.
extrapolated this linear relationship for predicted sensitivity estimates below 10 dB. This can
be seen in Figure 4.3. In this exploratory analysis, we found that the relationship was well
represented by the function ln(SD) = A+B× sensitivity(dB), where A and B are 2.60 dB and
-0.06 dB respectively. We extended Model 2 to incorporate this relationship in Model 3.
Model 3:
y∗iehlt = µ
(2)
iehlt + εiehlt ,
with
εiehlt ∼ N(0,σ2ε,iehlt),
and
log(σε,iehlt) = µζ0 +µζ1µ
(2)
iehlt , (4.3.3)
where σε,iehlt is the standard deviation for individual i = 1, . . . ,N; eye e = 1,2; hemifield
h = 1,2; location l = 1, . . . ,26 at time t = 1, . . . ,Ti. The priors for µζ0 and µζ1 are both N(0,
109). For the other parameters in Model 3 the priors are the same as those for Models 1 and
2. A summary of all parameters and their definitions for all the models is shown in Table 4.1.
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Figure 4.3: Bubbleplot representing the mean logarithm of the standard deviation for different predicted
sensitivity estimates determined using linear regression for each location. The predicted values were
subdivided into groups with width 5 dB. The empty bubbles correspond to the hypothetical values,
corresponding to the censored measurements, for the mean logarithm of the standard deviation for the
predicted sensitivity estimates after extrapolation. The bubbles are scaled to the logarithm of the number
of observations. Due to the small number of observations within the 35 dB to 40 dB range (0.02% of the
total observations), we excluded these measurements in the linear regression.
4.4 Estimation Approach
4.4.1 One-stage approach
The Bayesian approach takes into account the uncertainty in all model parameters and
allows prior information to be incorporated. Furthermore, MCMC algorithms allow greater
flexibility by relaxing the strong parametric assumptions commonly used in most frequentist
hierarchical models (Lunn et al., 2013; Lesaffre and Lawson, 2012). The classical Bayesian
approach is one-stage hierarchical modeling, which has the advantage that subject-specific
and overall parameters are estimated simultaneously. However, for a (relatively) large data
set, this approach can be difficult or even impossible to implement for complex models with
standard MCMC software. In our case, we had a total of 45,005 parameters which needed to
be estimated. As a consequence, we were unable to achieve convergence in a realistic time
frame and we experienced computer memory limitations when using WinBUGS or JAGS. For
such situations, a computationally more tractable method is needed.
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4.4.2 Two-stage approach
Lunn et al. (2013) proposed two-stage Bayesian hierarchical modeling. The two-stage
approach allowed us to simplify the problem by splitting hierarchical models with M levels at
level m∗. Independent parameters of interest at level m* are obtained in stage 1 and used
as proposal distributions for those parameters in stage 2. Lunn et al. (2013) illustrated
this method using models with two and three levels. The glaucoma data exhibit a similar
hierarchical structure to that presented by Lunn et al. (2013), but of a more complex nature
with four levels. Figure 6.8 illustrates the hierarchical structure of the glaucoma data, as well
as the cross-classified random effects, divided into two stages. In our case, we split the levels
at the individual level, treating each individual as their own sample. These individuals were
then analyzed independently before combining them to obtain population level estimates.
Table 4.1: Summary of parameters included cumulatively in each of the models
Model Parameter Definition
1 y∗iehlt Latent sensitivity estimate
µα0 Population-averaged intercept
µα1 Population-averaged slope
α0i Individual-specific intercept
α1i Individual-specific slope
γ0ie Deviation due to the eye (intercept)
γ1ie Deviation due to the eye (slope)
η0ieh Deviation due to the hemifield (intercept)
η1ieh Deviation due to the hemifield (slope)
λ0iehl Deviation due to the location (intercept)
λ1iehl Deviation due to the location (slope)
σ2ε Variance of the measurement error
Σα Covariance matrix for the individual level
Σγ Covariance matrix for the eye level
Ση Covariance matrix for the hemifield level
Σλ Covariance matrix for the location level
2 φiet Global visit effect
σ2φ Global Visit Effect variance
3 µζ0 Intercept in logarithm of the standard deviation
µζ1 Slope in logarithm of the standard deviation
σ2ε,iehlt Variance of the measurement error
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Figure 4.4: Illustration of the hierarchical structure of the data divided into the first and second stages as
done in the two-stage approach.
4.4.2.1 First stage
In the first stage, we analyzed each individual separately. This is now shown for Model 3.
The first stage model is given by:
y∗iehlt = α0i +α1itimeit + γ0ie + γ1ietimeit +η0ieh +η1iehtimeit +
λ0iehl +λ1iehl timeit +φiet + εiehlt , (4.4.4)
where εiehlt ∼ N(0,σ2ε,iehlt) and
log(σε,iehlt) = ζ0i +ζ1iµ
(2)
iehlt ,
44
4.4 Estimation Approach
and
αbi ∼ N(0,109) for b = 0,1;
γie =
( γ0ie
γ1ie
)∼ N((00) ,Σγi);
ηieh =
(η0ieh
η1ieh
)∼ N((00),Σηi);
λiehl =
(
λ0iehl
λ1iehl
)
∼ N((00) ,Σλi);
φiet ∼ t(0,σ2φi ,3);
σ2φi ∼ IG(10−3,10−3);
ζbi ∼ N(0,109) for b = 0,1.
Note that vague and independent priors are specified for α0i,α1i, because they are treated as
fixed effects in the first stage.
One important detail about the two-stage approach is that it allows the individual variances
to differ, i.e. Σγi , Σηi , Σλi and σ
2
φi , but also σ
2
ε,iehlt since the regression coefficients are now
allowed to depend on the subject. In order to prevent the second-stage sampler from getting
stuck near local posterior modes, large independent samples are needed from this first stage
(Lunn et al., 2013). To achieve this, we ran 200,000 iterations with a burn-in of 150,000
iterations. Using a thinning factor of 10, this resulted in 5,000 stored iterations for each
parameter for each individual.
4.4.2.2 Second stage
At the end of the first stage we have the following sampled values for the parameters split
up according to whether they will be directly used in the second stage (parameters of interest)
or not (nuisance parameters):
• Parameters of interest:
{α0i,α1i,ζ0i,ζ1i,Σγi ,Σηi ,Σλi ,σ2φi} for i = 1, . . . ,N;
• Nuisance parameters:
Ni = {γ0i1,γ1i1,γ0i2,γ1i2,η0i1,1, . . . ,η1i2,2,λ0i1,1,1, . . . ,λ1i2,2,26,φi1,1, . . . ,φi1,Ti ,φi2,1,
. . . ,φi2,Ti} for i = 1, . . . ,N.
The total set of nuisance parameters is then denoted asN = {N1, . . . ,NN}. The split up into
parameters of interest and nuisance parameters is motivated as follows. The αi = (α0i,α1i)T
and ζi = (ζ0i,ζ1i)T are transferred to the second stage, because we wish to estimate their
population-averaged effects assuming a common (normal) distribution with means equal to
µα = (µα0 ,µα1)T and µζ = (µζ0 ,µζ1)
T , respectively. Since we decided to split the data at the
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individual level for computational reasons, all lower-level random effects are automatically
considered to be nuisance. In the case of a meta-analysis, the random effects in the first stage
may not be of direct interest. Hence, these terms can then be treated as nuisance parameters
as done by Lunn et al. (2013). However, for clinical applications such as ours, these may
be important. So, we kept the covariance matrices of those lower-level random effects as
input for the second stage to allow us to re-estimate these random effects at a later stage. A
Cholesky decomposition of the covariance matrices of the random effects (Σγi , Σηi and Σλi )
was computed, since each of the entries in the covariance matrices were treated as separate
parameters in the second stage. For example, for Σγi the 2 × 2 full rank lower triangular
matrix
Cγi =
(
c1γi 0
c2γi c3γi
)
,
with c1γi ,c3γi positive diagonal entries such that CγiC
T
γi = Σγi . We denote
the Cholesky decomposition factors for all of the covariance matrices
as {c1γi ,c2γi ,c3γi ,c1ηi ,c2ηi ,c3ηi ,c1λi ,c2λi ,c3λi}. Hence, the final set of
parameters of interest that are directly processed in the second stage are
{αi,ζi,σ2φi ,c1γi ,c2γi ,c3γi ,c1ηi ,c2ηi ,c3ηi ,c1λi ,c2λi ,c3λi} for i = 1, . . . ,N.
In the second stage we assume that the above parameters of interest share a common
distribution. More specifically, we assumed here that αi ∼ N((µα0 ,µα1)T ,Σα ), σ2φi ∼
N(σ2φ ,σ
2
σ 2φ
). However, for ζ0i, ζ1i and all Cholesky decomposition parameters we assumed
independent normal distributions, because of computational and memory restrictions. We
refer to Section 4.8.2.3 for the priors. The posterior distributions of the aforementioned
parameters were then obtained by using their sampled values from the first stage as proposal
distributions in a Metropolis-Hastings step. Further details about the two-stage approach are
found in (Lunn et al., 2013).
The total set of parameters involved in the second stage is denoted asP and is given by:
P = {α01,α11, . . . ,α0N ,α1N ,µα0 ,µα1 ,Σα ,ζ01,ζ11, . . . ,ζ0N ,ζ1N ,µζ0 ,µζ1 ,σ2ζ0 ,σ
2
ζ1 ,σ
2
φ ,
σ2σ 2φ ,µc1γ ,µc2γ ,µc3γ ,µc1η ,µc2η ,µc3η ,µc1λ ,µc2λ ,µc3λ ,σ
2
c1γ ,σ
2
c2γ ,σ
2
c3γ ,σ
2
c1η ,σ
2
c2η ,σ
2
c3η ,
σ2c1λ ,σ
2
c2λ ,σ
2
c3λ },
where {µc1γ ,µc2γ ,µc3γ ,µc1η ,µc2η ,µc3η ,µc1λ ,µc2λ ,µc3λ } are defined in Section 4.8.2.3.
Three chains were initialized with different starting values for all models determined from
the first-stage samples. This was done using the minimum, mean and maximum sampled value
for each parameter for every individual. Upon convergence, we computed the posterior mean,
median, standard deviation with the equal-tailed 95% credible interval (CI) for all parameters
of interest.
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4.5 Model Evaluation
Classical approaches to model evaluation are applicable to the results of the first stage,
since this stage represents a standard analysis. Hence, we evaluated the models at this stage
for each individual separately by using posterior predictive checks (PPC), such as the χ2
test statistic. We further compared the models after the second stage by using the Deviance
Information Criterion (DIC) to determine the overall best model.
4.5.1 Deviance Information Criterion
In a Bayesian framework, a common tool for model evaluation is the DIC proposed by
Spiegelhalter et al. (2002) (Spiegelhalter et al., 2002). The DIC is based on a contrast between
the deviance at the posterior mean of the parameters and the posterior mean deviance. DIC is
defined here as
DIC = D(P¯, ¯N )+2pD = D(P,N )+ pD, (4.5.5)
with
pD = D(P,N )−D(P¯, ¯N ),
where the deviance is denoted as D(P,N ), the posterior expectation of the deviance is
denoted as D(P,N ) and the posterior means of the parameters P and N as P¯ and ¯N ,
respectively.
The definition of the DIC includes the parameters of interestP , which we obtained from
the second stage, as well as the random effectsN , which are treated as nuisance parameters
in the two-stage approach. In practice, DIC is usually computed conditional on the random
effects (so-called conditional DIC, see e.g. (Lesaffre and Lawson, 2012)). However, the
two-stage approach does not automatically provide estimates for all random effects under the
one-stage model.
To address this problem, we propose to complement the two-stage approach with
an additional step based on the Method of Composition (Lesaffre and Lawson, 2012) in
combination with a Metropolis-within-Gibbs technique. To illustrate our proposed method,
we refer again to Model 3. Note that for the calculation of DICs, we need the posterior
distribution p(N | y), with y the total set of observed VF data. The required posterior of the
random effects can be obtained from the posterior distribution p(P | y) and p(N |P,y) as
p(N | y) =
∫
p(N |P,y)p(P | y)dP. (4.5.6)
In practice the integral is replaced by a Monte Carlo estimate, by sampling each element of
N given y and the sampled value of P and then ignoring the sampled value P . This is in
fact an example of the Method of Composition.
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Let the vector of all responses for the individual i and eye e be denoted by yie.
Furthermore, let Nie represent the subset of nuisance parameters in N , for individual i and
eye e. For each eye e of each individual i, the computations of our proposed method for
sampling the random effects inNie consist of the following steps:
Step 1: We use the posterior results of K = 500 consecutive iterations of the second stage
of the two-stage approach. For iteration k (with k = 1, . . . ,K), let P˜(k) denote the sampled
values of the parameters of interest (P) estimated in the second stage. Conditional on P˜(k),
we sample the random effects inNie (for the eye, hemifield, location and GVE), which were
treated as nuisance parameters in the second stage, i.e.
γ0ie,γ1ie,η0ieh,η1ieh,λ0iehl ,λ1iehl and φiet ,
and we denote the sampled values as ˜N (k)ie . For each iteration k, the sampling of the random
effects is done with the Metropolis-within-Gibbs technique as described in Steps 2A and 2B
below.
Step 2A: For k = 1 we need to choose initial values for the random effects in ˜N (1)ie . To
decrease computational time, the posterior modes of all parameters in Nie were determined
by means of an optimisation routine, and these were used as initial values for ˜N (1)ie in Step
2B. The optimisation was performed using the optim() function in R with a quasi-Newton
algorithm. The function which was maximised with respect to Nie was the logarithm of
p(Nie | P¯,yie) ∝ p(yie | P¯,Nie) p(Nie | P¯). Note that the optimisation procedure is only
done for k = 1.
Step 2B: A random-walk Metropolis-Hastings algorithm is used to sample the random
effects iteratively for each level, to take into account the correlation between the levels,
yielding a Metropolis-within-Gibbs sampler. For example, first a sampled value for the eye
is obtained given the initial values for the levels lower than the eye (i.e. the hemifield, the
location and the GVE). This sampled value is then used in combination with the initial values
for the levels lower than the hemifield (i.e. the location and the GVE) to obtain an estimate
for the hemifield random effects, and so forth. This Metropolis-within-Gibbs sampler is run
for s = 1, . . . ,S iterations, with S = 200, and the random effects obtained in the last iteration
S are then used as the sampled random effects ˜N (k)ie in Step 1. The first S−1 iterations thus
only serve as burn-in samples. For k = 1, the estimates obtained in Step 2A are used as initial
values (for s = 1). For k = 2, . . . ,K, the sampled values of the previous iteration of Step 1, i.e.
˜N (k−1)ie are used as initial values.
In the Metropolis-within-Gibbs sampler, the random effects are sampled for each iteration
s (with s = 1, . . . ,S) as follows:
1. The random effects for the eye level (γ(s)ie ) are sampled by means of the
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Metropolis-Hastings algorithm with target density proportional to
∏
h
∏
l
∏
t
p(yiehlt | γie,η(s−1)ieh ,λ
(s−1)
iehl ,φ
(s−1)
iet ,P˜
(k))× p(γie | P˜(k)).
2. For hemifield h = 1,2, the random effects for the hemifield level (η(s)ieh) are sampled by
means of the Metropolis-Hastings algorithm with target density proportional to
∏
l
∏
t
p(yiehlt | γ(s)ie ,ηieh,λ (s−1)iehl ,φ
(s−1)
iet ,P˜
(k))× p(ηieh | P˜(k)).
3. For hemifield h = 1,2 and location l = 1, . . . ,26, the random effects for the location
level (λ (s)iehl) are sampled by means of the Metropolis-Hastings algorithm with target
density proportional to
∏
t
p(yiehlt | γ(s)ie ,η(s)ieh ,λiehl ,φ
(s−1)
iet ,P˜
(k))× p(λiehl | P˜(k)).
4. For visit t = 1, . . . ,Ti, the random effects for the GVE (φ
(s)
iet ) are sampled by means of
the Metropolis-Hastings algorithm with target density proportional to
∏
h
∏
l
p(yiehlt | γ(s)ie ,η(s)ieh ,λ
(s)
iehl ,φiet ,P˜
(k))× p(φiet | P˜(k)).
We let ˜N (k) denote all of the sampled values of N , i.e. the combined sampled values,
˜N (k)ie , for both eyes from all individuals. Combining the resulting samples of N with
the samples of P from the second stage yields a set of K = 500 posterior samples of
the parameters and random effects. These posterior samples are then used to calculate the
deviance in iteration k as
D(P,N )(k) =−2
N
∑
i=1
2
∑
e=1
2
∑
h=1
26
∑
l=1
Ti
∑
t=1
log(p(yiehlt | ˜N (k),P˜(k))),
and finally the DIC is calculated from these K deviance values.
4.5.2 Posterior predictive check
Let the vector of all responses for the ith individual be denoted by yi. Furthermore, we
denote all parameters for individual i from the first stage by ψi. Then suppose that ψ1i , . . . ,ψ
K
i
are samples from the converged Markov chain from p(ψi | yi). The posterior predictive
p-value (PPP) for a discrepancy measure DG(yi | ψki ) is obtained by contrasting this value
to DG(y˜ki ,ψ
k
i ) for k in {1, . . . ,K}, whereby the replicated data y˜ki are sampled from p(yi |ψki ).
The following p-value can then be calculated for the ith subject
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PPP =
1
K
K
∑
k=1
I[DG(y˜ki ,ψ
k
i )≤ DG(yi,ψki )]. (4.5.7)
Here, the Gelman χ2-test statistic (Gelman et al., 2013) was used as the discrepancy
measure to calculate the PPC for each individual. This is defined as:
DG(yi,ψki ) =
2
∑
e=1
2
∑
h=1
26
∑
l=1
Ti
∑
t=1
[yiehlt −E(yiehlt | ψki )]2
var(yiehlt | ψki )
, (4.5.8)
where a small value indicates a good model fit. When the PPP is small, say smaller than
0.05, the replicated data fit the assumed model importantly better than the observed data, and
hence we conclude in that case that our model does not fit the data well. In this hierarchical
structure, such a p-value can be computed for each individual. In case of a good model fit, we
expect that the distribution of p-values has a uniform distribution. Now because the data is
used twice: once for model fit and once for model evaluation (see e.g. Lesaffre and Lawson
(2012)) we will not obtain a uniform distribution for a good model fit, but rather a distribution
more clustered around 0.5. For the same reason, the approach does not provide an absolute
guarantee of a good model fit. But all improvements of the basic approach, see e.g. (Lesaffre
and Lawson, 2012), are computationally too time consuming here.
4.6 Application to the Glaucoma study
For this analysis we included both eyes from the 139 individuals belonging to the
Glaucoma study. After excluding VFs with unknown reliability as indicated by the instrument,
138 individuals; 276 eyes; 552 hemifields and 14,352 locations remained. This included 4,760
VFs, resulting in a data set consisting of 247,520 location-specific sensitivity estimates. All
analyses were done taking into account censoring.
4.6.1 Results
The two-stage approach is advantageous, as it allows us to do exploratory analyses at the
individual level in order to simplify the model before combining the samples in the second
stage. An example of the model fits for one location is shown in Figure 4.5. The posterior
summary statistics from the second stage are listed in Table 4.2 for each of the models. A
lower DIC indicates a preferable model. Using DIC, Model 2 (DIC=1,173,872) performed
better than Model 1 (DIC = 1,211,653), with Model 3 (DIC = 1,075,212 performing the best
overall. Using the results from Model 3, the population intercept (µα0 ) was 19.82 dB with an
average slope (µα1 ) of -0.31 dB per year. The intercept (µζ0 ) and slope (µζ1 ) for the logarithm
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of the standard deviation was 2.82 dB and -0.08 dB respectively. This corresponds to the 2.60
dB and -0.06 dB which was found in the exploratory analysis shown in Figure 4.3.
Figure 4.5: Scatter plot representing the retinal sensitivity estimates over time for 1 location of the VF.
The lines represent the model fits for each of the 3 models with 95% CIs.
To evaluate the fit of the chosen model(s) we can use the PPC technique. More
specifically, we could compute the PPP-value for each individual and then graphically evaluate
the distribution of p-values. Figure 4.6 shows the ordered PPP-values for each of the models.
Model 1 has a mean PPP = 0.30, Model 2 a mean PPP = 0.30 and Model 3 a mean
PPP = 0.50. From this, it appears that Model 3 has the best fit. That the distribution of
p-values should deviate from the uniform distribution for a good model was explained above.
In fact, we indeed see that for Model 3 the p-values are more clustered around 0.5 than what
would be expected if the true P-value had a uniform distribution. For the other two models
the distribution of p-values is systematically shifted to the left.
4.6.2 Comparing the models: some reflections
Our model takes into account the hierarchical structure of the data by means of a Bayesian
hierarchical model. This allows us to take into account the correlation at each of the 4
levels. The estimated covariance matrices for each level were similar for all models. A
large proportion of intercept variability was explained by the individual level random effects
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Figure 4.6: Posterior predictive check for each of the models across all individuals
Table 4.2: Posterior summary statistics for the three models by means of the two-stage approach
Model 1 2 3
Parameter mean sd 95% CI mean sd 95% CI mean sd 95% CI
µα0 18.97 0.73 (17.54 ; 20.39) 20.30 0.74 (18.86 ; 21.76) 19.89 0.77 (18.37 ; 21.39)
µα1 −0.23 0.05 (−0.33 ; −0.12) −0.20 0.05 (−0.30 ; −0.11) −0.30 0.05 (−0.40 ; 0.20)
µζ0 2.82 0.06 (2.69 ; 2.95)
µζ1 -0.08 0.00 (−0.08 ; −0.07)
σ 2ε,iehlt 13.46 0.66 (12.20 ; 14.81) 11.53 0.57 (10.45 ; 12.70)
σ 2φ 1.86 0.15 (1.58 ; 2.18) 5.64 0.12 (5.29 ; 5.91)
Σα
(63.79 0.06
0.06 0.20
) (71.11 −1.73
−1.73 0.16
) (76.10 −0.14
−0.14 0.17
)
Σγ
(0.44 −0.02
−0.02 0.23
) (0.45 −0.01
−0.01 0.27
) (0.00 0.01
0.01 0.96
)
Ση
(26.85 0.36
0.36 0.23
) (24.73 0.19
0.19 0.23
) (25.50 0.29
0.29 0.23
)
Σλ
(41.41 0.40
0.40 0.13
) (40.33 −0.19
−0.19 0.14
) (40.13 0.11
0.11 0.09
)
DIC 1,211,653 1,173,872 1,075,212
(Model 3: Σα11 = 76.10). A small amount of this intercept variability was explained by
the eye level random effects (Model 3: Σγ11 = 0.0007). This is due to the fact that each
individual only has 2 eyes and with this approach we assume that only the eyes belonging
to the same individual share a common variance distribution. This variability increases
for the 4 hemifields per individual (Model 3: Ση11 = 25.50) and for the 104 locations per
individual (Model 3: Σλ11 = 40.13). The variance of the slope for the hemifield (Model
3: Ση22 = 0.23) seems to be large compared to the variance of the slope for the location
(Model 3: Σλ22 = 0.09). This shows that locations within a hemifield are correlated with
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respect to their change. This is expected, since the nerves within each hemifield belong to
the same nerve bundle. Hence, it is likely that there is some correlation between nerves, and
hence locations, which are affected by glaucomatous damage. It is important to note that all
individuals received therapy throughout the study. The range of slopes may be reduced with
therapy, because the intra-ocular pressure (IOP) range is reduced between eyes to somewhat
similar levels. Without therapy the individual’s IOP would be between 15 and 40 mmHg.
With therapy this could be reduced to between 12 and 24 mmHg. Since all individuals in this
study are being treated, the reduction in the IOP range could explain the small range of slopes
of progression.
We proposed to model measurement errors that affect the point-wise sensitivity estimates
within the same VF as GVEs. By correcting for the GVEs, we account for measurable
factors, such as season, time of day and the reliability indices, as well as those factors which
cannot be measured such as fatigue and delayed reaction time. Including the GVE showed a
considerable improvement in the model fit. Hence, by taking into account the GVE we were
able to take into account a large part of the variability and obtain better estimates of the true
rate of progression. Implementing progression models that incorporate the GVE in clinical
care may therefore improve the clinical management of glaucoma. A further evaluation of
the GVE by determining the improvement of the model fit due to incorporating the GVE in
the model and the effect of including the GVE on estimating the rate of progression has been
done in previous work. Furthermore, the improvement of point-wise predictions for future
measurements accounting for the GVE has been shown (Bryan et al., 2015).
Including the relationship between variability and sensitivity showed a further
improvement in the model fit. The function which describes this relationship was consistent to
that found by Henson et al. (2000), however it was not shown previously how to include this
relationship in a model, or whether including it would improve the model fit. Other studies
have emphasized the importance of this relationship and questioned the validity of assuming a
constant variance over the entire range of sensitivity estimates (Russell et al., 2012). Gardiner
et al. (2014) showed that clinical VF testing may be unreliable when VF locations have
sensitivity estimates below approximately 15-19 dB. By modeling this relationship, we are
able to account for the lower sensitivity estimates being less reliable and hence allow the
precision throughout the range of sensitivity estimates to differ accordingly.
In clinical practice, it is often difficult to determine which patients progress rapidly
towards severe visual impairment and which ones are relatively stable, because of
measurement variability. With our current approach, the true rate of progression is much
better determined, so that clinicians can specifically target those with rapid progression,
thereby significantly reducing the risk of severe visual impairment or blindness.
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4.7 Discussion
In this paper, we proposed a method to model point-wise VFs taking into account
the complexity of psychophysical testing of visual function in glaucoma. The model is
advantageous in dealing with the high measurement variability, and could be extended for
the prediction of future VFs. Although it was possible to use the one-stage approach with
simplified versions of the model or with smaller datasets, it was not possible to perform
these analysis on the full data with a complex model as it was with the two-stage approach.
The two-stage approach can be implemented in standard MCMC software. The relevant
computations for the first-stage can be carried out in JAGS (Plummer, 2003), WinBUGS or
OpenBUGS (Lunn et al., 2009) software and the second-stage carried out in OpenBUGS
software (Lunn et al., 2013). However, for the second stage an add-on program is needed.
For more details on setting up OpenBUGS for performing the two-stage analyses, we refer
to (Lunn et al., 2013). More information regarding the computations done in this paper can
be obtained by emailing the first author. These computations can be easily tuned to adapt to
other data sets by any practitioner.
The two-stage method is advantageous as it allowed us to do exploratory analysis at an
individual level. Hence, we are able to simplify and improve the model before combining
it at a population level. Limited simulations showed that the one- and two-stage approaches
gave similar results if the variances were the same for all individuals. The two-stage approach
assumes a more flexible method. However, there is the additional difficulty in constraining the
parameters across individuals. One disadvantage of this approach is that it does not provide
the required components to evaluate the fit and predictive ability of the model by means of the
Deviance Information Criterion (DIC). In order to calculate the DIC and compare different
competing models for our data fitted by using the two-stage approach, we proposed a Monte
Carlo scheme based on a Metropolis-within-Gibbs algorithm.
Other issues, which we see as future research directions, is to look at the optimal choice
of the level where the data should be split. Extensions include exploiting the spatial nature
of the data and capitalizing on the specific spatial organization of the nerve fibres in the eye
(Erler et al., 2014).
Acknowledgements
The authors would like to thank Dr. Baoyue Li for his useful discussions which
helped with the early stages of this work. The authors would also like to thank Stichting
Wetenschappelijk Onderzoek het Oogziekenhuis, Stichting voor Ooglijders and Stichting
Glaucoomfonds for the financial support. Furthermore, the authors would like to thank the
editor and the referees for their helpful comments and suggestions which drastically improved
the quality of the manuscript.
54
BIBLIOGRAPHY
Bibliography
Anderson, D. R. and Patella, V. M. (1999). Automated Static Perimetry. Mosby, 2nd edition.
Artes, P. H., Nicolela, M. T., LeBlanc, R. P., and Chauhan, B. C. (2005). Visual
field progression in glaucoma: total versus pattern deviation analyses. Investigative
Ophthalmology & Visual Science, 46(12):4600.
Bengtsson, B. and Heijl, A. (2000). False-negative responses in glaucoma perimetry:
indicators of patient performance or test reliability? Investigative Ophthalmology & Visual
Science, 41(8):2201–2204.
Bengtsson, B. and Heijl, A. (2008). A visual field index for calculation of glaucoma rate of
progression. American Journal of Ophthalmology, 145(2):343–353.
Bryan, S. R., Vermeer, K. A., Eilers, P. H. C., Lemij, H. G., and Lesaffre, E. M. E. H. (2013).
Robust and censored modeling and prediction of progression in glaucomatous visual fields.
Investigative Ophthalmology & Visual Science, 54(10):6694–6700.
Caprioli, J., Mock, D., Bitrian, E., Afifi, A. A., Yu, F., Nouri-Mahdavi, K., and Coleman,
A. L. (2011). A method to measure and predict rates of regional visual field decay in
glaucoma. Investigative Ophthalmology & Visual Science, 52(7):4765–4773.
Erler, N. S., Bryan, S. R., Eilers, P. H. C., Lesaffre, E. M. E. H., Lemij, H. G.,
and Vermeer, K. A. (2014). Optimizing structure-function relationship by maximizing
correspondence between glaucomatous visual fields and mathematical retinal nerve fiber
models. Investigative Ophthalmology & Visual Science, 55(4):2350–2357.
Gelfand, A. E. and Smith, A. F. M. (1990). Sampling-based approaches to calculating
marginal densities. Journal of the American Statistical Association, 85(410):398–409.
Gelman, A., Carlin, J. B., Stern, H. S., Dunson, D. B., Vehtari, A., and Rubin, D. B. (2013).
Bayesian Data Analysis. Chapman and Hall/CRC, Boca Raton, 3rd edition.
Henson, D. B., Chaudry, S., Artes, P. H., Faragher, E. B., and Ansons, A. (2000). Response
variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension,
and normal eyes. Investigative Ophthalmology & Visual Science, 41(2):417–421.
Hoffman, M. D. and Gelman, A. (2014). The No-U-Turn Sampler: adaptively setting
path lengths in Hamiltonian Monte Carlo. Journal of Machine Learning Research,
15(1):1593–1623.
Prediction of Visual Prognosis 55
BIBLIOGRAPHY
Hudson, C., Wild, J. M., and O’Neill, E. C. (1994). Fatigue effects during a single session
of automated static threshold perimetry. Investigative Ophthalmology & Visual Science,
35(1):268–280.
Junoy Montolio, F. G., Wesselink, C., Gordijn, M., and Jansonius, N. M. (2012). Factors that
influence standard automated perimetry test results in glaucoma: test reliability, technician
experience, time of day, and season. Investigative Ophthalmology & Visual Science,
53(11):7010–7017.
Kingman, S. (2004). Glaucoma is second leading cause of blindness globally. Bulletin of
the World Health Organization, 82(11):887–888.
Kymes, S. M., Lambert, D. L., Lee, P. P., Musch, D. C., Siegfried, C. J., Kotak, S. V.,
Stwalley, D. L., Fain, J., Johnson, C., and Gordon, M. O. (2012). The development of a
decision analytic model of changes in mean deviation in people with glaucoma: the COA
model. Ophthalmology, 119(7):1367–1374.
Lee, K. J. and Thompson, S. G. (2008). Flexible parametric models for random-effects
distributions. Statistics in Medicine, 27(3):418–434.
Lesaffre, E. and Lawson, A. B. (2012). Bayesian Biostatistics. Wiley & Sons, Chichester,
West Sussex.
Lunn, D., Barrett, J., Sweeting, M., and Thompson, S. (2013). Fully Bayesian hierarchical
modelling in two stages, with application to meta-analysis. Journal of the Royal Statistical
Society. Series C, Applied Statistics, 62(4):551–572.
Lunn, D., Spiegerhalter, D., Thomas, A., Best, N. (2009). The BUGS project: Evolution,
critique and future directions. Statistics in Medicine, 28(25):3049–3067.
McNaught, A. I., Crabb, D. P., Fitzke, F. W., and Hitchings, R. A. (1995). Modelling series of
visual fields to detect progression in normal-tension glaucoma. Graefe’s Archive for Clinical
and Experimental Ophthalmology, 233(12):750–755.
Ntzoufras, I. (2009). Bayesian Modeling Using WinBUGS. Wiley & Sons, Hoboken, N.J.
Pathak, M., Demirel, S., and Gardiner, S. K. (2013). Nonlinear, multilevel mixed-effects
approach for modeling longitudinal standard automated perimetry data in glaucoma.
Investigative Ophthalmology & Visual Science, 54(8):5505.
Plummer, M. (2003). JAGS: A Program for Analysis of Bayesian Graphical Models Using
Gibbs Sampling.
56
BIBLIOGRAPHY
Rue, H., Martino, S., and Chopin, N. (2009). Approximate Bayesian inference for latent
Gaussian models by using integrated nested Laplace approximations. Journal of the Royal
Statistical Society: Series B (Statistical Methodology), 71(2):319–392.
Russell, R. A., Crabb, D. P., Malik, R., and Garway-Heath, D. F. (2012). The relationship
between variability and sensitivity in large-scale longitudinal visual field data. Investigative
Ophthalmology & Visual Science, 53(10):5985–5990.
Spiegelhalter, D. J., Best, N. G., Carlin, B. P., and Van Der Linde, A. (2002). Bayesian
measures of model complexity and fit. Journal of the Royal Statistical Society: Series B
(Statistical Methodology), 64(4):583–639.
Swanson, W. H., Sun, H., Lee, B. B., and Cao, D. (2011). Responses of primate
retinal ganglion cells to perimetric stimuli. Investigative Ophthalmology & Visual Science,
52(2):764–771.
Tobin, J. (1958). Estimation of relationships for limited dependent variables. Econometrica,
26(1):24–36.
Verbeke, G. and Molenberghs, G. (2000). Linear Mixed Models for Longitudinal Data.
Springer Series in Statistics. Springer New York, New York, NY.
Zhu, H., Russell, R. A., Saunders, L. J., Ceccon, S., Garway-Heath, D. F., and Crabb, D. P.
(2014). Detecting changes in retinal function: Analysis with non-stationary Weibull error
regression and spatial enhancement (ANSWERS). PLoS ONE, 9(1):e85654.
Prediction of Visual Prognosis 57
BIBLIOGRAPHY
4.8 Appendix A: Model Specifications
In this section, the model specifications for Model 3 are given for the one-stage and
two-stage approach.
4.8.1 One-Stage Approach
4.8.1.1 Full Model
y∗iehlt = α0i +α1itimeit + γ0ie + γ1ietimeit +
η0ieh +η1iehtimeit +λ0iehl +λ1iehl timei j +φiet + εiehlt (4.8.1)
where εiehlt ∼ N(0,σ2ε,iehlt) and log(σε,iehlt) = µζ0 +µζ1µ
(2)
iehlt .
4.8.1.2 Priors
In the Bayesian procedure prior distributions need to be stipulated for all parameters.
When no prior information is available then the prior distribution should reflect this. In this
case a vague prior is a natural choice.
αi =
(α0i
α1i
)∼ N((µα0µα1 ) ,Σα)
γie =
( γ0ie
γ1ie
)∼ N((00) ,Σγ )
ηieh =
(η0ieh
η1ieh
)∼ N((00),Ση )
λiehl =
(
λ0iehl
λ1iehl
)
∼ N((00) ,Σλ )
φiet ∼ t(0,σ2φ ,3)
µζb ∼ N(0,109) for b = 0,1
µαb ∼ N(0,109) for b = 0,1
σ2φ ∼ IG(10−3,10−3) and
Σα ,Σγ ,Ση and Σλ ∼ IW(diag(1,1),2).
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4.8.2 Two-Stage Approach
The full model is the same for both the one-stage and two-stage approach. Priors for
µα and αi are also the same for both approaches. However, the covariance matrices for γie,
ηieh and λiehl , the scale parameter for φiet as well as ζi are subject-specific in the two-stage
approach.
4.8.2.1 Full model priors
αi =
(α0i
α1i
)∼ N((µα0µα1 ) ,Σα)
γie =
( γ0ie
γ1ie
)∼ N((00) ,Σγi)
ηieh =
(η0ieh
η1ieh
)∼ N((00),Σηi)
λiehl =
(
λ0iehl
λ1iehl
)
∼ N((00) ,Σλi)
φiet ∼ t(0,σ2φi ,3)
ζbi ∼ N(µζb ,σ2ζb) for b = 0,1
µαb ∼ N(0,109) for b = 0,1
σ2φi ∼ N(σ2φ ,σ2σ 2φ )
σ2φ ∼ IG(10−3,10−3)
σ2σ 2φ ∼ IG(10
−3,10−3)
µζb ∼ N(0,109) for b = 0,1
σ2ζb ∼ IG(10
−3,10−3) for b = 0,1 and
Σαi ,Σγi ,Σηi and Σλi ∼ IW(diag(1,1),2).
4.8.2.2 First Stage Priors
αbi ∼ N(0,109) for b = 0,1
σ2φi ∼ IG(10−3,10−3)
ζbi ∼ N(0,109) for b = 0,1
Σαi ,Σγi ,Σηi and Σλi ∼ IW(diag(1,1),2)
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4.8.2.3 Second Stage Priors
αi =
(α0i
α1i
)∼ N((µα0µα1 ) ,Σα )
σ2φi ∼ N(σ2φ ,σ2σ 2φ )
ζbi ∼ N(µζb ,σ2ζb) for b = 0,1
µαb ∼ N(0,108) for b = 0,1
Σα ∼ IW(diag(1,1),2)
σ2φ ∼ IG(10−3,10−3)
σ2σ 2φ ∼ IG(10
−3,10−3)
µζb ∼ N(0,109) for b = 0,1
σ2ζb ∼ IG(10
−3,10−3) for b = 0,1
Using Cholesky decomposition, Σγi , Σηi and Σλi become,
crγi ∼ N(µcrγ ,σ2crγ ) for r = 1,2,3
crηi ∼ N(µcrη ,σ2crη ) for r = 1,2,3
crλi ∼ N(µcrλ ,σ2crλ ) for r = 1,2,3
µcrγ ,µcrη ,µcrλ ∼ N(0,109) for r = 1,2,3
σ2crγ ,σ
2
crη ,σ
2
crλ ∼ IG(10−3,10−3) for r = 1,2,3.
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4.9 Appendix B: Methods
In this section, the different stages within the two-stage approach are described in detail.
Again, we use Model 3 for illustration purposes. Let
αi = {α01,α11, . . . ,α0,N ,α1,N}
ζi = {ζ01,ζ11, . . . ,ζ0,N ,ζ1,N}
Cγi = {c1γ1 ,c2γ1 ,c3γ1 , . . . ,c1γN ,c2γN ,c3γN}
Cηi = {c1η1 ,c2η1 ,c3η1 , . . . ,c1ηN ,c2ηN ,c3ηN}
Cλi = {c1λ1 ,c2λ1 ,c3λ1 , . . . ,c1λN ,c2λN ,c3λN}.
To simplify the notation, we let Ci denote all of the Cholesky decomposition parameters in
Cγi , Cηi and Cλi . In the spirit of Lunn et al. (2013), we are interested in the parameters of
interest from the first stage, namely, αi,ζi,Ci,σ2φi . The population averages and covariance
matrices for αi are given by µα and Σα . The population averages and variances for ζi,Ci,σ2φi
are given by µζ ,µc,σ2φ and σ
2
ζ ,σ
2
c ,σ2σ 2φ
respectively, where
µα = {µα01 ,µα02}
µζ = {µζ01 ,µζ02}
µc = {µc1γ ,µc2γ ,µc3γ ,µc1η ,µc2η ,µc3η ,µc1λ ,µc2λ ,µc3λ }
and
σ2ζ = {σ2ζ01 ,σ
2
ζ02}
σ2c = {σ2c1γ ,σ2c2γ ,σ2c3γ ,σ2c1η ,σ2c2η ,σ2c3η ,σ2c1λ ,σ2c2λ ,σ2c3λ }.
4.9.1 Full Model
The joint posterior distribution for Model 3 by means of the two-stage approach is given
by,
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p(µα ,µζ ,µc,σ
2
φ ,Σα ,σ
2
ζ ,σ
2
c ,σ
2
σ 2φ
,α1, . . . ,αN ,ζ1, . . . ,ζN ,C1, . . . ,CN ,σ2φ1 , . . . ,σ
2
φN ,∝
N | y)p(µα )p(µζ )p(µc)p(σ2φ )p(Σα )p(σ2ζ )p(σ2c )p(σ2σ 2φ )×
N
∏
i=1
{
p(yi | αi,ζi,Ci,σ2φi ,Ni)p(αi | µα ,Σα ) p(ζi | µζ ,σ2ζ ) p(Ci | µc,σ2c )×
p(σ2φi | σ2φ ,σ2σ 2φ )p(Ni).
(4.9.2)
4.9.2 First Stage
We analyse all individuals independently from the joint posterior distribution of each
αi,ζi,Ci conditional on yi alone,
p(αi,ζi,Ci,σ2φi ,Ni | yi) ∝ p(yi | αi,ζi,Ci,σ2φi ,Ni)p(αi,ζi,Ci,σ2φi)p(Ni)
i = 1, ...,N. (4.9.3)
4.9.3 Second Stage
From distribution (B.1) the posterior distributions for the second stage are given by,
p(µα ,µζ ,µc,σ
2
φ | Σα ,σ2ζ ,σ2c ,σ2σ 2φ ,α1, . . . ,αN ,ζ1, . . . ,ζN ,C1, . . . ,CN ,σ
2
φ1 , . . . ,σ
2
φN ,N ,y) ∝
p(µα ,µζ ,µc,σ
2
φ )
N
∏
i=1
p(αi,ζi,Ci,σ2φi | µα ,µζ ,µc,σ2φ ,Σα ,σ2ζ ,σ2c ,σ2σ 2φ )
(4.9.4)
p(Σα ,σ2ζ ,σ
2
c ,σ
2
σ 2φ
| µα ,µζ ,µc,σ2φ ,α1, . . . ,αN ,ζ1, . . . ,ζN ,C1, . . . ,CN ,σ2φ1 , . . . ,σ2φN ,N ,y) ∝
p(Σα ,σ2ζ ,σ
2
c ,σ
2
σ 2φ
)
N
∏
i=1
p(αi,ζi,Ci,σ2φi | µα ,µζ ,µc,σ2φ ,Σα ,σ2ζ ,σ2c ,σ2σ 2φ )
(4.9.5)
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p(αi,ζi,Ci,σ2φi ,Ni | µα ,µζ ,µc,σ2φ ,Σα ,σ2ζ ,σ2c ,σ2σ 2φ ,y) ∝
p(yi | αi,ζi,Ci,σ2φi ,Ni)p(αi,ζi,Ci,σ2φi | µα ,µζ ,µc,σ2φ ,Σα ,σ2ζ ,σ2C,σ2σ 2φ )p(Ni)
i = 1, ...,N. (4.9.6)
The distributions from (B.3) and (B.4) are available in closed form and hence we can
sample from them directly by using standard algorithms. For the distributions (B.5) we use the
distributions in (B.2) as the proposal distributions within a Metropolis-Hastings step. For the
Metropolis-Hastings algorithm, the target-to-proposal ratio, denoted as R, can be simplified
to,
R(αi,ζi,Ci,σ2φi ,Ni) ∝
p(yi | αi,ζi,Ci,σ2φi ,Ni)
p(yi | αi,ζi,Ci,σ2φi ,Ni)
×
p(αi,ζi,Ci,σ2φi | µα ,µζ ,µc,σ2φ ,Σα ,σ2ζ ,σ2c ,σ2σ 2φ )p(Ni)
p(αi,ζi,Ci,σ2φi)p(Ni)
=
p(αi,ζi,Ci,σ2φi | µα ,µζ ,µc,σ2φ ,Σα ,σ2ζ ,σ2c ,σ2σ 2φ )
p(αi,ζi,Ci,σ2φi)
(4.9.7)
i = 1, ...,N.
For more details regarding the two-stage approach, we refer to (Lunn et al., 2013).
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4.10 Supplementary Material
In this section we describe the steps used in this chapter. This includes the code used to
run each of the stages of the modeling process. Furthermore, we include plots showing the
convergence assessment at each of the stages. We focus on the final model (Model 3) which
was the most complex model to fit.
4.10.1 A: Data
’data.frame’: 247520 obs.
id : unique eye ranging from 1 to 138
eye : unique eye ranging from 1 to 276
hemi : unique hemifield ranging from 1 to 552
pos : unique location ranging from 1 to 14350
field : unique visual field ranging from 1 to 4760
years : time in years
y.cens : response variable ranging from 0 to 40 with
censored values as NA
thres : response variable ignoring censoring
4.10.2 B: Code
4.10.2.1 First Stage
The first stage of the two-stage approach for our specific data set is implemented in jags by means of
the rjags package.
### Model
model.stageOne <- function() {
for (i in 1:n.obs){
is.cens[i] ~ dinterval(y.cens[i], -0.000001)
y.cens[i] ~ dnorm(mu[i],tau[i])
mu[i] <- lambda[pos[i],1] + years[i] *
lambda[pos[i], 2] + phi[visit[i]]
### Relationship between sentivity and variabilty
log.Sigma[i] <- zeta[id[eye[hemi[pos[i]]]],1] +
zeta[id[eye[hemi[pos[i]]]], 2] * mu[i]
Sigma[i] <- exp(log.Sigma[i])
tau[i] <- pow(Sigma[i], -2)
}
### Individual Level
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for(k1 in 1:n.ind){
for (g in 1:2){alpha[k1, g] ~ dnorm(0, 0.000000001)}
for (q in 1:2){zeta[k1, q] ~ dnorm(0, 0.000000001)}
tau.visit[k1] ~ dgamma(0.001,0.001)
tau.pos[k1,1:2,1:2] ~ dwish(Omega[,], 2)
tau.hemi[k1,1:2,1:2] ~ dwish(Omega[,], 2)
tau.eye[k1,1:2,1:2] ~ dwish(Omega[,], 2)
sigma.field[k1] <- 1/tau.field[k1]
sigma.pos[k1, 1:2, 1:2] <- inverse(tau.pos[k1,,])
sigma.hemi[k1, 1:2, 1:2] <- inverse(tau.hemi[k1,,])
sigma.eye[k1, 1:2, 1:2] <- inverse(tau.eye[k1,,])
}
### Eye Level
for(k2 in 1:n.eye){
gamma[k2, 1:2] ~ dmnorm(alpha[id[k2],],
tau.eye[id[k2],,])
}
### Hemisphere Level
for(k3 in 1:n.hemi){
eta[k3, 1:2] ~ dmnorm(gamma[eye[k3], 1:2],
tau.hemi[id[eye[k3]],,])
}
### Location Level
for(k4 in 1:n.pos){
lambda[k4, 1:2] ~ dmnorm(eta[hemi[k4], 1:2],
tau.pos[id[eye[hemi[k4]]],,])
}
### Visit Level
for(k5 in 1:n.visit){
phi[k5] ~ dt(0, tau.visit[v[k5]], 3)
}
Omega[1, 1] <- 1
Omega[1, 2] <- 0
Omega[2, 1] <- 0
Omega[2, 2] <- 1
}
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Parameters of interest need to be followed and saved as an array ’samples’.
In our case, the parameters of interest include alpha, zeta, sigma.eye,
sigma.hemi, sigma.pos and sigma.visit.
4.10.2.2 Second Stage
In the second stage we use the samples saved in the first stage as proposal
distributions for the MH-algorithm. This is implemented by means of the Black
Box version of OpenBUGS.
### Model
model{
for (i in 1:N){
dummy[i] ~ dproposem(theta[i, 1:p],samples[i, 1:p, 1:L])
theta[i, 1:p] ~ dmnorm(mu[1:p], tau.theta[,])
}
### Priors
for(m in 1:13){
mu[m] ~ dnorm(0, 0.000001)
}
mu[14] <- log(sigma.visit)
sigma.field <- 1/tau.visit
tau.visit ~ dgamma(0.001, 0.001)
tau.theta[1,1] <- tau.theta1[1, 1]
tau.theta[1,2] <- tau.theta1[1, 2]
tau.theta[2,1] <- tau.theta1[2, 1]
tau.theta[2,2] <- tau.theta1[2, 2]
tau.theta1[1:2,1:2] ~ dwish(Omega[,],2)
sigma2.theta1 <- inverse(tau.theta1[,])
Omega[1,1]<-1
Omega[1,2]<-0
Omega[2,1]<-0
Omega[2,2]<-1
for(j in 3:14){
tau.theta[j,j] ~ dgamma(0.001, 0.001)
}
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}
The samples from this stage need to be saved as coda files to be used in R version
3.0.1.
4.10.2.3 Extension
This stage is done for each eye separately using the parameters estimated in the
second stage. This is implemented in R.
Step 2A:
Initial values are determined using the following optimization routine:
SIGMA.eye <- rep(list(SIGMA0.eye), length(unique(dat2$eye)))
SIGMA.eye <- do.call(adiag, SIGMA.eye)
SIGMA.hemi <- rep(list(SIGMA0.hemi), length(unique(dat2$hemi)))
SIGMA.hemi <- do.call(adiag, SIGMA.hemi)
SIGMA.pos <- rep(list(SIGMA0.pos), length(unique(dat2$pos)))
SIGMA.pos <- do.call(adiag, SIGMA.pos)
M <- vector()
fr <- function(thetas){
tht <- relist(thetas, list.thetas)
eye.int <- tht$eye.int
eye.slope <- tht$eye.slope
hemi.int <- tht$hemi.int
hemi.slope <- tht$hemi.slope
pos.int <- tht$pos.int
pos.slope <- tht$pos.slope
field.offset <- tht$field.offset
Fixted <- mean(ind.int[ ,unique(id)]) +
mean(ind.slope[ ,unique(id)])*years
M <- Fixted + eye.int[eye2] + eye.slope[eye2] * years +
hemi.int[hemi2] + hemi.slope[hemi2] * years +
pos.int[pos2] + pos.slope[pos2] * years +
field.offset[field2]
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proposal <- sum(not.cens * dnorm(thres, mean=M,
sd=exp(mean(b0.sd)+
mean(b1.sd) * M),
log = T)) +
sum(is.cens * pnorm(thres, mean=M,
sd=exp(mean(b0.sd)+
mean(b1.sd) * M),
log.p = T)) +
dmvnorm(as.vector(rbind(eye.int, eye.slope)),
mean = rep(c(0), length(unique(eye)) * 2),
sigma = SIGMA.eye,log=T) +
dmvnorm(as.vector(rbind(hemi.int, hemi.slope)),
mean=rep(c(0), length(unique(hemi)) * 2),
sigma=SIGMA.hemi,log=T) +
dmvnorm(as.vector(rbind(pos.int, pos.slope)),
mean=rep(c(0), length(unique(pos)) * 2),
sigma = SIGMA.pos,log=T) +
sum(dgt(field.offset, mu = 0,
sigma = mean(field.sd), df=3))
-(proposal)
}
dgt <- function(x, mu, sigma, df){
dt((x - mu)/sigma,df = df,log = T)-log(sigma)}
list.thetas <- NULL
list(eye.int = rep(c(0),length(unique(eye))),
eye.slope = rep(c(0), length(unique(eye))),
hemi.int = rep(c(0), length(unique(hemi))),
hemi.slope = rep(c(0), length(unique(hemi))),
pos.int = rep(c(0), length(unique(pos))),
pos.slope = rep(c(0), length(unique(pos))),
field.offset = rep(c(0), length(unique(field))))
thetas <- NULL
thetas <- unlist(as.relistable(list.thetas))
inits <- c(rep(c(0), length(unique(eye))),
rep(c(0), length(unique(eye))),
rep(c(0), length(unique(hemi))),
rep(c(0), length(unique(hemi))),
rep(c(0), length(unique(pos))),
rep(c(0), length(unique(pos))) ,
rep(c(0), length(unique(field))))
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o <- optim(inits, fr, method = "BFGS",
control = list(parscale = rep(0.001,
length(inits))))
gc()
results <- o$par
eye.int1 <- results[1]
eye.slope1 <- results[2]
hemi.int1 <- results[3:4]
hemi.slope1 <- results[5:6]
pos.int1 <- results[7:58]
pos.slope1 <- results[59:110]
field.offset1 <- results[111:length(results)]
Step 2B:
A random walk Metropolis-Hastings algorithm is used for each of the levels.
This is done iteratively, to take into account the correlation between the levels. This
implemented in R version 3.0.1.
### Function which can be used for the eye, hemifield and
### location level to estimate the proposal and
### target distributions
like <- function(Fixted, bi.level, bt.level,
SIGMA.level, level){
Fixted = Fixted
bi.level = bi.level
bt.level = bt.level
mean.p = Fixted + bi.level[,1] + bi.level[,2] * years
mean.t = Fixted + bt.level[,1] + bt.level[,2] * years
SIGMA.level = SIGMA.level
level = level
proposal = rowsum(not.cens * dnorm(thres,
mean = mean.p,
sd = exp(b0.sd[i] + b1.sd[i] * mean.t),
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log = T), group = level) +
rowsum(is.cens*pnorm(thres,
mean = mean.p,
sd = exp(b0.sd[i] + b1.sd[i] * mean.p),
log.p = T), group = level) +
dmvnorm(bi.level[,], mean=c(0,0),
sigma=SIGMA.level, log = T)
target = rowsum(not.cens * dnorm(thres,
mean = mean.t,
sd = exp(b0.sd[i] + b1.sd[i] * mean.t),
log = T), group = level) +
rowsum(is.cens * pnorm(thres,
mean =mean.t,
sd = exp(b0.sd[i] + b1.sd[i] * mean.t),
log.p=T), group = level)+
dmvnorm(bt.level[,], mean=c(0,0),
sigma = SIGMA.level, log = T)
p = proposal - target
p
}
### This is run first as an adaption phase to ensure that
### the acceptance rate is between 20-40 percent.
### Once the variance has been determined for the proposal
### distribution at each level,
### this can be run and the results saved.
for(j in l:u)
{
### RANDOM EFFECTS FOR THE EYE LEVEL
bi.eye <- rmvnorm(1, mean = c(bt.eye[,1], bt.eye[,2]),
sigma = SIGMA0.eye * var.change.eye)
Fixted <- proposal <- target <- vector()
Fixted <- i.ind.int + i.ind.slope*years +
hemi.int[j-1,hemi2] +
hemi.slope[j-1,hemi2] * years +
pos.int[j-1,pos2] +
pos.slope[j-1,pos2] * years +
field.offset[j-1,field2]
p <- like(Fixted, bi.eye, bt.eye, SIGMA.eye, eye2)
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rho = exp(p)
r.unif = runif(1)
bt.eye[,1] <- eye.int[j-1,] + (bi.eye[,1] -
eye.int[j-1,]) * (r.unif < rho)
bt.eye[,2] <- eye.slope[j-1,] + (bi.eye[,2] -
eye.slope[j-1,]) * (r.unif < rho)
eye.int[j,] <- as.numeric(bt.eye[,1])
eye.slope[j,] <- as.numeric(bt.eye[,2])
a <- bt.eye[,1]
b <- eye.int[j-1,]
count1.eye[a != b] <- count1.eye[a != b] + 1
count2.eye <- count2.eye + 1
### RANDOM EFFECTS FOR THE HEMIFIELD LEVEL
SIGMA.hemi1 <- rep(list(SIGMA0.hemi), length(unique(hemi)))
SIGMA.hemi1 <- do.call(adiag, SIGMA.hemi1)
Fixted <- proposal <- target <- vector()
Fixted <- i.ind.int + i.ind.slope * years +
eye.int[j, eye2] +
eye.slope[j, eye2] * years +
pos.int[j-1, pos2] +
pos.slope[j-1, pos2] * years +
field.offset[j-1, field2]
bi.hemi <- matrix(rmvnorm(1, mean = as.vector(rbind(
bt.hemi[,1], bt.hemi[,2])),
sigma = SIGMA.hemi1 *
rep(var.change.hemi, each = 2)),
ncol = 2, byrow = T)
p <- like(Fixted, bi.hemi, bt.hemi, SIGMA.hemi, hemi2)
rho <- exp(p)
r.unif <- runif(2)
bt.hemi[,1] <- hemi.int[j-1,] + (bi.hemi[,1] -
hemi.int[j-1,]) * (r.unif < rho)
bt.hemi[,2] <- hemi.slope[j-1,] + (bi.hemi[,2] -
hemi.slope[j-1,]) * (r.unif < rho)
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hemi.int[j,] <- as.numeric(bt.hemi[,1])
hemi.slope[j,] <- as.numeric(bt.hemi[,2])
a <- bt.hemi[,1]
b <- hemi.int[j-1,]
count1.hemi[a != b] <- count1.hemi[a != b] + 1
count2.hemi <- count2.hemi+1
a <- bt.hemi[,1]
b <- hemi.int[j-1,]
count1.hemi[a != b] <- count1.hemi[a != b] + 1
count2.hemi <- count2.hemi+1
### RANDOM EFFECTS FOR THE LOCATION LEVEL
SIGMA.pos1 <- rep(list(SIGMA0.pos), length(unique(pos)))
SIGMA.pos1 <- do.call(adiag, SIGMA.pos1)
Fixted <- proposal <- target <- vector()
Fixted <- i.ind.int + i.ind.slope * years +
eye.int[j, eye2] +
eye.slope[j, eye2] * years +
hemi.int[j, hemi2] +
hemi.slope[j, hemi2] * years +
field.offset[j-1, field2]
bi.pos <- matrix(rmvnorm(1,mean = as.vector(rbind(
bt.pos[,1], bt.pos[,2])),
sigma = SIGMA.pos1 *
rep(var.change.pos, each = 2)),
ncol = 2, byrow = T)
p <- like(Fixted, bi.eye, bt.eye, SIGMA.eye,
eye2, n.unif)
rho <- exp(p)
r.unif <- runif(52)
bt.pos[,1] <- pos.int[j-1,] + (bi.pos[,1] -
pos.int[j-1,]) * (r.unif < rho)
bt.pos[,2] <- pos.slope[j-1,] + (bi.pos[,2] -
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pos.slope[j-1,]) * (r.unif < rho)
pos.int[j,] <- as.numeric(bt.pos[,1])
pos.slope[j,] <- as.numeric(bt.pos[,2])
a <- bt.pos[,1]
b <- pos.int[j-1,]
count1.pos[a != b] <- count1.pos[a != b] + 1
count2.pos <- count2.pos + 1
### RANDOM EFFECTS FOR THE FIELD LEVEL
Fixted<-proposal<-target<-vector()
Fixted <- i.ind.int + i.ind.slope * years +
eye.int[j, eye2] +
eye.slope[j, eye2] * years +
hemi.int[j, hemi2] +
hemi.slope[j, hemi2] * years +
pos.int[j, pos2] +
pos.slope[j, pos2] * years
bi.field <- rnorm(n = N.field, mean = bt.field,
sd = mean(field.sd) * var.change.field)
proposal <- as.numeric(rowsum(not.cens * dnorm(thres,
mean = Fixted +
bi.field[field2],
sd = exp((b0.sd[i]) +
(b1.sd[i]) *
(Fixted + bi.field[field2])),
log = T), group = field2) +
rowsum(is.cens * pnorm(thres,
mean = Fixted +
bi.field[field2],
sd = exp((b0.sd[i]) +
(b1.sd[i]) *
(Fixted + bi.field[field2])),
log.p = T), group = field2) +
as.numeric(dgt(bi.field, mu = 0,
sigma = field.sd[i], df = 3)))
target <- as.numeric(rowsum(not.cens * dnorm(thres,
mean = Fixted +
bt.field[field2],
sd = exp((b0.sd[i]) +
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(b1.sd[i]) *
(Fixted + bt.field[field2])),
log = T), group = field2) +
rowsum(is.cens * pnorm(thres,
mean = Fixted +
bt.field[field2],
sd = exp((b0.sd[i]) +
(b1.sd[i]) * (Fixted +
bt.field[field2])),
log.p = T),
group = field2) +
as.numeric(dgt(bt.field, mu = 0,
sigma = field.sd[i], df = 3)))
p <- proposal - target
rho <- exp(p)
r.unif <- runif(N.field)
bt.field <- field.offset[j-1,] + (bi.field-
field.offset[j-1,]) * (r.unif < rho)
field.offset[j,] <- as.numeric(bt.field)
a <- bt.field
b <- field.offset[j-1,]
count1.field[a != b] <- count1.field[a != b] + 1
count2.field <- count2.field + 1
}
74
4.10 Supplementary Material
4.10.3 C: Convergence Assessment
In this section we include plots showing the convergence of certain parameters
at each stage of the modeling process.
4.10.3.1 First stage
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Figure 4.7: Convergence plots for individual 7.
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Figure 4.8: Autocorrelation plots for individual 7.
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Figure 4.9: Autocorrelation plots for individual 89.
4.10.3.2 Second stage
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4.10.3.3 Extension
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Figure 4.11: Convergence plots for individual 5.
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Figure 4.12: Convergence plots individual 9.
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CHAPTER5
Comparison of Estimation Methods for Multilevel
Models
This Chapter is based on: Bryan, S.R., Lesaffre, E.M.E.H., van Rosmalen, J.M., Noh, M., Lee,
Y. and Rizopoulos, D. Comparison of estimation methods for multilevel models. Submitted.
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5. Comparison of Estimation Methods for Multilevel Models
Abstract
The Bayesian approach has become increasingly popular because it allows to fit quite
complex models to data via Markov chain Monte Carlo (MCMC) sampling. However, it
is also recognized nowadays that MCMC sampling can become computationally prohibitive
when applied to a large data set. To overcome these issues we have investigated three
possible approaches that address the computational burden in a hierarchical model, namely,
the two-stage MCMC approach, Integrated nested Laplace approximation (INLA) and
Hierarchical likelihood (H-likelihood) and compare these to the classical one-stage approach.
Since these methods approximate the solution of the classical one-stage MCMC approach,
something is gained and lost with each approach. The aim of this paper is to compare these
three alternative methods from a statistical and practical viewpoint. The motivating data set is
an ongoing Dutch glaucoma study. Glaucoma is one of the leading causes of blindness in the
world. In order to detect deterioration at an early stage, a model for predicting visual fields
(VF) in time is needed. Hence, the true underlying VF progression can be determined, and
treatment strategies can then be optimized to prevent further VF loss. A simulation study was
done to evaluate and compare the different approaches.
5.1 Introduction
The Bayesian approach has become increasingly popular from a conceptual and practical
viewpoint. Firstly, the Bayesian approach allows for prior information to be incorporated and
takes into account all uncertainty in the model parameters. Secondly, it allows to fit quite
complex models to data via Markov chain Monte Carlo (MCMC) sampling. Furthermore,
MCMC algorithms allow greater flexibility by relaxing the strong parametric assumptions
commonly used in most frequentist hierarchical models (Lesaffre and Lawson, 2012). The
classical Bayesian approach to hierarchical modeling is done in one stage, i.e. subject-specific
and overall parameters are estimated simultaneously. However, this approach might be
prohibitive in practice with a large number of repeated measurements in combination with
a complex hierarchical structure.
The motivating data that we consider in this paper is taken from an ongoing Dutch glaucoma
study conducted by the Rotterdam Eye Hospital in the Netherlands. The Glaucoma study
provides a unique database of longitudinally measured visual field (VF) data. From a
statistical modelling viewpoint the analysis of the VF data presents several challenges. First,
VF testing involves measuring the level of differential light sensitivity at different locations
within each eye. The sensitivity estimates are left-censored due to the limitation of the device
used to measure them. Furthermore, VF data have a hierarchical structure consisting of 4
levels, namely, (1) the individual, (2) the eye, (3) the hemifield and (4) the location. Another
difficulty in modelling VF data is the amount and type of measurement error in the sensitivity
estimates. This may be due to measurable factors, such as season, time of day and reliability
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indices, or unknown transient factors, such as fatigue or lack of concentration. Although
their magnitudes may vary, these factors are global and affect all locations belonging to the
same eye at each visit. To model these factors, cross-classified random effects for each visit
are needed. Furthermore, to accommodate spikes in the distribution of the visit effects, a
distribution which allows flexibility and can handle heavy tails should be assumed (i.e. a
t-distribution). Including these aspects in the modelling approach has been investigated in
previous research (Bryan et al., 2017, 2015). A problem with high dimensional data and
complex data structures such as this data set, is that it is sometimes difficult or even impossible
to model them with standard MCMC software.
To overcome these issues, we previously analysed the glaucoma data using the two-stage
MCMC approach (Lunn et al., 2013; Bryan et al., 2017). In this paper, we compare the
two-stage MCMC approach to the classical one-stage MCMC approach. Furthermore, we
investigate two alternative approaches, namely, the INLA approach (Rue et al., 2009) and the
H-likelihood approach (Lee and Nelder, 1996) and compare them to the classical one-stage
approach. Since these methods approximate the one-stage approach, something is gained
and lost with each approach. We investigate these approaches from a statistical and practical
viewpoint using both real data, as well as data simulated for different scenarios. The rest of
the paper is structured as follows. In Section 2 we provide the working model. The estimation
approaches are described in Section 3. In the subsequent section we give further details on
the motivating data set and apply the computational approaches to the Glaucoma study data.
Section 5 describes the simulation study which was done to compare the different approaches.
Finally, Section 6 contains a concluding discussion.
5.2 The Bayesian Hierarchical Model
The computational approaches will be introduced via a hierarchical model involving
subjects followed-up in time, also called a mixed-effects model. Let yit denote the follow-up
measurements for the i-th individual (i = 1, . . . ,n) where t denoted the specific time-point
t = 1, . . . ,mi. Furthermore, let yi denote all observations for individual i and y denote the
observations for all individuals combined. The Gaussian mixed-effects model can be written
as
yit = x>it β + z>it αi + εit ,
αi ∼ N(0,Σα ),
εit ∼ N(0,σ2),
where β denotes the vector with the regression coefficients of the design matrix for the fixed
effects xi and zi denotes the design matrix for the random effects αi. In particular, the fixed and
the random effects refer to the population-average and subject-specific effects, respectively.
Furthermore, Σα is the covariance-variance matrix of the random effects, εit are the error
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terms and σ2 is the variance of the error. Additionally, αi is assumed to be independent of εit
and the εit are assumed to be independent of each other for i = 1, . . . ,n and t = 1, . . . ,mi.
5.3 Bayesian Estimation Techniques
5.3.1 Markov chain Monte Carlo techniques
For complex models, the posterior distribution often cannot be determined analytically.
Calculating the integral using numerical integration methods is a practical alternative if only
a few parameters are involved, but it becomes difficult for real-life applications where the
dimensionality is often high Lesaffre and Lawson (2012). These problems can be avoided by
using sampling techniques yielding Markov chains. A popular class of sampling algorithms
is Markov chain Monte Carlo (MCMC) methods.
5.3.1.1 One-stage approach
The classical MCMC approach to Bayesian hierarchical modeling is done in one
stage, which has the advantage that subject-specific and overall parameters are estimated
simultaneously. For the model in (1) and assuming a simple structure for αi which only
includes an individual-specific intercept (α0i) and slope for time (α1i), we have for the i-th
individual (i = 1, . . . ,n) and specific time-point (t = 1, . . . ,mi),
yit = α0i +α1itimeit + εit ,
where
αi = (α0i,α1i)T ∼ N((β0,β1)T ,Σα ),
εit ∼ N(0,σ2),
with priors σ2 ∼ p(σ2), β ∼ p(β ) and Σα ∼ p(Σα ). The joint posterior distribution is then
given by,
p(α,σ2,β ,Σα | y) ∝ (
n
∏
i=1
mi
∏
t=1
N(yit | αi,σ2))(
n
∏
i=1
N(αi | β ,Σα ))p(σ2)p(β ,Σα ). (5.3.1)
However, the MCMC approach can be difficult or even impossible to implement for
complex models with standard software. In the motivating data set for this paper, we
consider a 4-level model which includes 30858 random effects in total. Computation problems
arise when looking at these large data sets, including memory issues, as well as problems
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obtaining convergence in a realistic time frame. For these issues, using cluster computing
is not a solution since all parameters need to be estimated simultaneously. Hence, a more
computationally efficient method is needed for such situations. This is described in more
detail by Bryan et al. (2017).
5.3.1.2 Two-stage approach
Having explained in the previous section the complexities of using the full Bayesian
approach, in the following subsection we present three alternative procedures that may
considerably decrease the computational burden and make it feasible to fit highly complex
multilevel mixed models. The first solution we present is the two-stage approach which was
previously used to model the glaucoma data by Bryan et al. (2015). The two-stage approach
was proposed by Lunn et al. (2013). This approach has been originally suggested in the
context of a meta-analysis. To adapt the approach to our setting, we can select a particular
level l from the L level multilevel structure, fit the corresponding Nl models at this level. To
obtain the final results we then need to appropriately utilize the different MCMC samples.
Lunn et al. (2013) proposed a two-stage approach, which allows us to simplify the
problem while still benefiting from the advantages of a full Bayesian model. In the two-stage
approach the variances σ2l are forced to differ for each subgroup in level l. For the simplified
case described above, we split the model at the individual level, and the model is for the i-th
individual (i = 1, . . . ,n) and specific time-point (t = 1, . . . ,mi),
yit = α0i +α1itimeit + εit ,
where
αi = (α0i,α1i)T ∼ N((β0,β1)T ,Σα ),
εit ∼ N(0,σ2i ),
with priors σ2i ∼ p(σ2i ), β ∼ p(β ) and Σα ∼ p(Σα ). The joint posterior distribution is then
given by,
p(α,σ2,β ,Σα | y) ∝ p(β )p(Σα )(
n
∏
i=1
mi
∏
t=1
N(yit | αi,σ2i ))(
n
∏
i=1
N(αi | β ,Σα ))p(σ2i ) (5.3.2)
where α and σ2 are the collection of all αis and σ2i s respectively.
Note that the classical one-stage approach can be adapted in the same way to allow
the variances to differ for each individual i.
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5.3.1.3 Stage 1
The two-stage approach allows to simplify the problem by splitting the hierarchical
models with K levels at level k, in this case at the individual level. By doing this, we are
able to run the analysis for the individuals in parallel, thereby considerably reducing the
computational time. Independent parameters of interest at the individual level are estimated
in stage 1. In this example, the individual variances σ2i are treated as nuisance parameters.
We first analyse each individual independently, to obtain a sample of size Bi for i = 1, . . . ,N.
The samples are obtained from the joint posterior distribution of each αi and σ2i , conditional
on yi, i.e.
p(αi,σ2i | yi) ∝ p(yi | αi,σ2i )p(αi)p(σ2i ) for i = 1, . . . ,n. (5.3.3)
5.3.1.4 Stage 2
The samples obtained from stage 1 are then used as proposal distributions for those
parameters in stage 2. In this stage, the joint posterior distribution of β , Σα , α and σ2
is sampled under the full hierarchical model. At each iteration one cycles through the full
conditional distributions for β , Σα and then each αi and σ2i jointly. These are given by,
p(β | Σα ,α,σ2,y) ∝ p(β )
n
∏
i=1
p(αi | β ,Σα ), (5.3.4)
p(Σα | β ,α,σ2,y) ∝ p(Σα )
n
∏
i=1
p(αi | β ,Σα ), (5.3.5)
p(αi,σ2i | β ,Σα ,y) ∝ p(yi | αi,σ2i )p(αi | β ,Σα )p(σ2i ), i = 1, . . .n. (5.3.6)
Multivariate normal and inverse Wishart priors can be specified for β and Σα respectively.
Hence, the distributions from (5.3.4) and (5.3.5) are available in closed form and can
hence be sampled directly by using standard algorithms. For the distribution in equation
(5.3.6) the distributions in equation (5.3.3) are used as proposal distributions within a
Metropolis-Hastings step. For this, the target-to-proposal ratio, denoted as R, is given by,
for i = 1, . . . ,n:
R(αi,σ2i ) =
p(αi | β ,Σα )
p(αi)
(5.3.7)
Let bi j be a uniformly chosen index from {1, . . . ,Bi} at each iteration j. By using flat
priors for the αi in stage 1, these samples are then based solely on the likelihood. Then
{α(bi j)i ,σ
2(bi j)
i } is accepted with probability min(1,A′), where
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A′ =
p(α(bi j)i | β ( j),Σ( j)α )
p(α( j−1)i | β ( j),Σ( j)α )
p(α( j−1)i )
p(α(ci j)i )
=
p(α(bi j)i | β ( j),Σ( j)α )
p(α( j−1)i | β ( j),Σ( j)α )
(5.3.8)
where β ( j) and Σ( j)α denote the values of β and Σα respectively at iteration j of the
Gibbs-Metropolis scheme.
Two-stage models can be performed very quickly, providing scope for rapid exploration
of different models. An extension of the two-stage approach to allow for the calculation of
model selection and model evaluation criteria by including an additional step based on the
Method of Composition in combination with a Metropolis-within-Gibbs technique has been
proposed (Bryan et al., 2017).
5.3.2 Methods based on Laplace approximation
5.3.2.1 Integrated nested Laplace approximation
Integrated nested Laplace approximation (INLA) has been proposed as a computationally
convenient alternative for MCMC methods (Rue et al., 2009). Laplace approximation is
a method for approximating integrals in Bayesian models based on a second-order Taylor
approximation of the log posterior, which results in a Gaussian approximation to the
posterior. INLA performs a nested version of the classical Laplace approximation combined
with modern numerical techniques for sparse matrices, which enables computationally fast
approximate Bayesian inference. The method applies only to latent Gaussian models, which
are a subset of Bayesian additive models with a structured additive predictor and Gaussian
priors for the model parameters in the additive predictor (Rue et al., 2016). The multi-level
hierarchical model implemented in this paper can be seen as an instance of a latent Gaussian
model, provided that all random effects and model residuals are assumed to be normally
distributed.
The model parameters can be divided into the latent Gaussian variables α and β , which
have normal prior distributions, and the hyperparameters σ2 and Σα , which do not necessarily
have a normal prior. INLA computes an approximation to the posterior in three steps. First the
joint posterior distribution of the hyperparameters σ2 and Σα is approximated using Laplace
approximation, according to
p˜i(σ2,Σα |y) ∝ pi(α,β ,σ
2,Σα ,y)
p˜iG(α,β |σ2,Σα ,y)
∣∣∣∣
α=α∗(σ 2,Σα ),β=β ∗(σ 2,Σα )
, (5.3.9)
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where p˜iG(α,β |σ2,Σα ,y) is the Gaussian approximation to the full conditional distribution
pi(α,β |σ2,Σα ,y), and α∗(σ2,Σα ) and β ∗(σ2,Σα ) represent the estimated mode of the full
conditional distribution as a function of the hyperparameters. The posterior distribution of
the hyperparameters p˜i(σ2,Σα |y) is then explored. This step does not require parametric
representation, but rather a sufficient exploration to be able to select good evaluation points
for the numerical integration of the final step.
In the second step, the posterior distribution of the parameters pi(α,β |σ2,Σα ,y) is
approximated using a Gaussian approximation, another Laplace approximation or a simplified
version of the Laplace approximation. In the third step, the first two steps are combined by
using numerical integration with
p˜i(αi|y) =∑
s
p˜i(αi|σ2s ,Σα,s,y)p˜i(σ2s ,Σα,s|y)∆s
p˜i(β |y) =∑
s
p˜i(β |σ2s ,Σα,s,y)p˜i(σ2s ,Σα,s|y)∆s,
where σ2s ,Σα,s denote the evaluation points obtained in the first step, ∆s the corresponding
area weights, and p˜i(αi|σ2s ,Σα,s,y) and p˜i(β |σ2s ,Σα,s,y) are the approximations obtained in
the second step. For a more extensive explanation on INLA, we refer to Rue et al. (2009)(Rue
et al., 2009).
5.3.2.2 Hierarchical likelihood
The hierarchical likelihood (H-likelihood) approach has been proposed as a conceptually
simple and reliable inferential procedure for models with general random effect structures.
Consider the h-likelihood of Lee and Nelder (1996) of the form,
h = `1(β ,θ)+ `2(θ), (5.3.10)
where `1(β ,θ) = log fβ ,θ (y|α) = ∑it log fβ ,θ (yit |αi) and `2(θ) = log fθ (α) = ∑i log fθ (αi).
In this section, we use fθ (·) to denote the density functions of random variables with
parameters θ ; the arguments within the brackets can be either conditional or unconditional.
Thus, fθ (y,α) and fθ (y|α) have different functional forms even though we use the same fθ (·)
to indicate density functions with parameters θ .
This h-likelihood exp(h) is proportional to the posterior p(α,β ,θ |y) when (β ,θ)
have uniform priors. Maximum likelihood (ML) estimators maximize the log-(marginal)
likelihood m = log
∫
exp(h)dα, whose asymptotic efficiency is well established. However,
the marginal likelihood is often hard to obtain and numerically intractable, especially when
the dimensionality of the integral is high. In such cases, Lee and Nelder (2001) considered an
adjusted profile likelihood function class aξ (l), defined by
aξ (l) = [l−
1
2
logdet{D(l,ξ )/(2pi)}]|ξ=ξ˜
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where D(l,ξ ) = −∂ 2l/∂ξ 2 and ξ˜ solves ∂ l/∂ξ = 0. Note that aα (h) is the Laplace
approximation to m (Lee and Nelder, 2001), which often gives accurate approximation
(Tierney and Kadane, 1986). In a normal linear mixed model, aβ (m)= aβ ,α (h)= log fθ (y|βˆ ),
where fθ (y|βˆ ) is the restricted likelihood hood of Patterson and Thompson (1971). This
gives the restricted (or residual) ML (REML) estimator for θ . For a detailed discussion see
Lee et al. (2006). Here, the function aβ ,α (h) means that both random and fixed effects are
simultaneously eliminated from h. Lee and Nelder (2001) showed that aβ ,α (h)' log fθ (y|βˆ )
to the first order approximation (Cox and Reid, 1987). The function class aξ () is useful in
making adjusted profile likelihoods, eliminating nuisance effects ξ , fixed or random or both.
Thus, aα (h) is used to obtain the ML estimators for β and aβ ,α (h) is used to obtain the REML
estimators for θ . The h-likelihood approach also allow to estimate the ML estimators for θ
by using aα (h).
Lee and Kim (2017) (Lee and Kim, 2017) showed that asymptotically h-likelihood and
Bayesian inferences become equivalent. Thus, with large samples, the optimization procedure
based on h-likelihood provides an efficient way of computing relevant quantities for the
Bayesian inference without having to resort to MCMC sampling.
5.4 Application
According to the World Health Organization, glaucoma is one of the leading causes
of irreversible blindness in the world. Due to the progressive nature of the disease, it is
important to detect deterioration at an early stage. Evaluation of a longitudinal series of visual
fields (VF), as measured by standard automated perimetry, provides a way to detect early
evidence of glaucoma and to determine functional deterioration. Hence, the true underlying
VF progression can be determined, and treatment strategies can then be optimized to prevent
further VF loss.
5.4.1 Motivating data set: the Glaucoma Study
The Glaucoma Study is a prospective cohort study conducted by the Rotterdam Eye
Hospital in the Netherlands. This is an ongoing study which began in 1998. Inclusion
criteria included glaucoma diagnosis and an age range of 18 to 85 years. In total, 139
patients, consisting of 80 (57.6%) men and 59 (42.4%) women, were recruited with a mean
follow-up of 10.5 years. Follow-up data were collected at approximately 6-monthly intervals.
All patients gave their written informed consent for participation. All research procedures
followed the tenets set forth in the Declaration of Helsinki. Furthermore, all of the data that
was used in this analysis has been made available online at http://rod-rep.com (Bryan et al.,
2013; Erler et al., 2014).
Sensitivity estimates were measured at 52 test locations within each eye, or 26 test locations
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within each hemifield (excluding two locations corresponding to the blind spot). The VFs
were tested using the Humphrey Field Analyzer with the 24-2, white-on-white test strategy
using the Full Threshold algorithm. The light source can be attenuated in the range from 1
to 10,000 times. On the decibel (dB) scale an attenuation x is defined as s = 10 log10(x), or
x = 10s/10. The lowest sensitivity that can be detected by this perimeter is 0 dB, although
negative values could in fact occur if it were not for the limitations of this device. The highest
sensitivity that can be detected is 50 dB, however few humans are capable of seeing a stimulus
less than 40 dB, which is 1/10,000 of the maximum intensity of the instrument (or 1 asb).
Thus, for practical purposes, the useful intensity range for white light testing is from 0 to 40
dB with a background illumination of 31.5 asb. (Anderson and Patella, 1999).
5.4.2 Previous research
To account for the aforementioned features of the VF data we recently proposed a
multilevel Bayesian mixed effects model with nested and crossed random effects (Bryan
et al., 2017). We proposed to model factors (such as season, time of day and fatigue) which
affect all locations belonging to the same VF as Global Visit Effects (GVEs) (Bryan et al.,
2015). In this way, we can account for both the known and the unknown factors. The
sensitivity estimates are left-censored due to a limitation of the device. Let the observed
sensitivity estimate be denoted by y∗ and the latent, true sensitivity value denoted by y.
Let yearsit represent the time between measurement t and the first measurement for each
individual i, ranging from 0 to 10.5 years. We then have, for individual i = 1, . . . ,N; eye
e = 1,2; hemifield h = 1,2; location l = 1, . . . ,26 and visit t = 1, . . . ,Ti,
Full Model:
yiehlt = β0 +β1yearsit +α0i +α1iyearsit + γ0ie + γ1ieyearsit +η0ieh +
η1iehyearsit +λ0iehl +λ1iehlyearsit +φiet + εiehlt . (5.4.1)
Here, β = (β0,β1)T corresponds to the population averaged intercept and slope of time.
The individual-specific intercept and slope of time for individual i are represented by α0i
and α1i, with deviations due to the eye given by γ0ie and γ1ie, due to the hemifield by η0ieh
and η1ieh, and due to the location by λ0iehl and λ1iehl . The GVE is represented by an extra
parameter, φiet . This captures the offset at every visit t for each eye e within each individual
i. To accommodate the large number of spikes in the distribution of the GVE, we assume a
t-distribution for φiet with 3 degrees of freedom.
The combination of the 4-level hierarchical structure with the cross-classified random
effects makes fitting the full Bayesian model a challenging task. As a consequence, we were
unable to achieve convergence in a realistic time frame and experienced computer memory
limitations with the classical one-stage MCMC approach and using standard software such as
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WinBUGS or JAGS. To overcome this limitation we used the two-stage approach of Lunn et
al. (2013).
5.4.3 Model for comparisons
To compare the four approaches, we use a simplified version of the proposed model
which was used by Bryan et al. (2017), as described in Section 5.4.2. Let yearsit represent the
time between measurement t and the first measurement for each individual i, ranging from
0 to 10.5 years. For this simple model, we ignore the censoring since INLA cannot handle
the deterministic mapping between yiehlt and y?iehlt . Furthermore, we exclude the GVE since
INLA is unable to model the cross-classified random effects with a t-distribution. Hence,
we use the observed sensitivity values, y∗iehlt . We then have, for individual i = 1, . . . ,N; eye
e = 1,2; hemifield h = 1,2; location l = 1, . . . ,26 and visit t = 1, . . . ,T ,
Simplified model:
y∗iehlt = α0i +α1iyearsit + γ0ie + γ1ieyearsit +
η0ieh +η1iehyearsit +λ0iehl +λ1iehlyearsit + εiehlt (5.4.2)
where
βp ∼ N(0,108) for p = 0,1; αi = (α0i,α1i)T ∼ N((β0,β1)T ,Σα )
γie = (γ0ie,γ1ie)T ∼ N((0,0)T ,Σγ ); ηieh = (η0ieh,η1ieh)T ∼ N((0,0)T ,Ση )
λiehl = (λ0iehl ,λ1iehl)T ∼ N((0,0)T ,Σλ ) and εiehlt ∼ N(0,σ2).
We performed two different analyses splitting the two-stage approach splitting the levels
in different ways. In the first analysis, we split the levels at the individual level, treating each
individual as their own sample. These individuals were then analyzed independently before
combining them to obtain population level estimates. The changed priors in the full model are
as follows,
γie = (γ0ie,γ1ie)T ∼ N((0,0)T ,Σγi); ηieh = (η0ieh,η1ieh)T ∼ N((0,0)T ,Σηi)
λiehl = (λ0iehl ,λ1iehl)T ∼ N((0,0)T ,Σλi) and εiehlt ∼ N(0,σ2i ).
In the second analysis, we split the levels at the eye level, treating each eye as their own
sample. The changed priors in the full model are as follows,
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ηieh = (η0ieh,η1ieh)T ∼ N((0,0)T ,Σηi)
λiehl = (λ0iehl ,λ1iehl)T ∼ N((0,0)T ,Σλi) and εiehlt ∼ N(0,σ2i ).
Uninformative priors were given for the variances and covariance matrices.
5.4.4 Software
The majority of the programs were run using R (R Foundation for Statistical Computing,
2013). The one-stage approaches, as well as the first stage of the two-stage approach were
implemented using the rjags package. The second stage of the two-stage approach was run
in OpenBUGS (Lunn et al., 2013). The H-likelihood approach was implemented using a
self-written program by the 3rd author. INLA was implemented using the R-INLA package.
5.4.5 Results
For this analysis we included both eyes from the 139 individuals belonging to the
Glaucoma study. This included 4,758 VFs, resulting in a data set consisting of 247,416
location-specific sensitivity estimates. A comparison of the classical one-stage, R-INLA and
the H-likelihood approaches can be seen in Table 5.1.
Table 5.1: Summary statistics for the simplified model
Parameter One-stage R-INLA H-Likelihood
β0 20.74 (0.52) 20.77 (0.52) 20.37 (0.55)
β1 -0.18 (0.03) -0.18 (0.03) -0.23 (0.03)
σ2 12.35 12.39 13.85
Σα
(20.56 −0.53
−0.53 0.10
) (23.53 −0.35
−0.35 0.10
) (30.50 −0.37
−0.37 0.13
)
Σγ
(15.88 −0.22
−0.22 0.06
) (14.72 −0.20
−0.20 0.06
) (17.49 −0.04
−0.04 0.07
)
Ση
(35.58 0.02
0.02 0.08
) (38.91 −0.07
−0.07 0.08
) (42.23 0.23
0.23 0.11
)
Σλ
(30.20 −0.36
−0.36 0.09
) (31.06 −0.21
−0.21 0.10
) (34.20 0.27
0.27 0.11
)
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A comparison of the one-stage and two-stage approaches, splitting the model at the
individual level, i.e. allowing σ2, Σγ , Ση and Σα to differ for every individual i and treating
them as nuisance parameters can be seen in Table 5.2.
Table 5.2: Summary statistics when dividing the data at the individual level
Parameter One-stage Two-stage
β0 21.36 (0.60) 20.97 (0.56)
β1 -0.15 (0.06) -0.18 (0.04)
Σα
(32.64 −0.45
−0.45 0.07
) (39.85 −1.03
−1.03 0.14
)
A comparison of the one-stage and two-stage approaches, splitting the model at the eye
level, i.e. allowing σ2, Ση and Σα to differ for every eye e and treating them as nuisance
parameters can be seen in Table 5.3.
Table 5.3: Summary statistics when dividing the data at the eye level
Parameter One-stage Two-stage
β0 21.21 (0.57) 20.88 (0.55)
β1 -0.15 (0.03) -0.19 (0.03)
Σα
(20.13 −0.31
−0.31 0.05
) (22.78 −0.49
−0.49 0.10
)
Σγ
(28.29 −0.23
−0.23 0.04
) (34.62 −0.15
−0.15 0.04
)
5.4.6 Discussion of the results
The results using the classical one-stage approach, R-INLA and H-likelihood gave
consistent results. The population averaged-intercepts were found to be 20.74 dB, 20.77 dB
and 20.37 dB, respectively for the three approaches. An intercept of approximately 20 dB
indicates that the patients within this data set have fairly moderate glaucoma at presentation.
The population-averaged slopes were indicative of slow progression and found to be −0.18
dB/year,−0.18 dB/year and−0.23 dB/year while the variances were found to be 12.35, 12.39
and 13.85 for each of the approaches respectively. The two-stage results differ from the above
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mentioned approaches because of the assumptions we make when allowing the lower levels of
the model to differ per individual (or per eye). These results are consistent with the one-stage
approach when making the same assumptions with both approaches. When splitting the model
at the individual level, the population-averaged intercepts were found to be 21.39 dB and
20.97 dB and the population-averaged slopes were found to be −0.15 dB/year and −0.18
dB/year for the one-stage approach and the two-stage approach, respectively. When splitting
the model at the eye level, the population-averaged intercepts were found to be 21.21 dB and
20.88 dB and the population-averaged slopes were found to be −0.15 dB/year and −0.19
dB/year, respectively. Hence, the results were found to be similar for all models irrespective
of which level the model was split at. It is important to note that all individuals received
therapy throughout the study and this could explain the small range of slopes of progression.
Our model takes into account the hierarchical structure of the data. This allows us
to take into account the correlation at each of the 4 levels. The estimated covariance
matrices for each level were similar for the classical one-stage approach, R-INLA and
H-likelihood. A large proportion of intercept variability was explained by the individual
level random effects for the classical one-stage approach, R-INLA and H-likelihood
(Σα11 = 20.56 dB, 23.53 dB and 30.50 dB). A smaller amount of this intercept variability
was explained by the eye level random effects (Σγ11 = 15.88 dB, 14.72 dB and 17.49 dB).
This is due to the fact that each individual only has 2 eyes and with this approach
we assume that only the eyes belonging to the same individual share a common
variance distribution. This variability increases for the 4 hemifields per individual
(Ση11 = 35.58 dB, 38.91 dB and 42.23 dB) and for the 104 locations per individual (Σλ11 =
30.20 dB, 31.06 dB and 34.20 dB).
The variances were higher for the level that we split the data at for the one-stage approach
when making the same assumptions as the two-stage approach. These results are similar to
the variances obtained from the two-stage approach. The individual level intercept variability
was found to be 32.64 dB and 39.85 dB for the two approaches when dividing the data at
the individual level. The individual level intercept variability was found to be 20.13 dB and
22.78 dB and the eye level intercept variability was found to be 28.29 dB and 34.62 dB for
the two approaches when dividing the data at the eye level. The increased variability of these
two approaches can be explained by the different model assumptions that are used for these
approaches compared to that of the classical one-stage, R-INLA and H-likelihood approaches.
5.5 Simulation study
A simulation was set up to evaluate the performance and to compare the different
approaches. The design of the simulated data was similar to the models that were fitted on
the glaucoma data. A brief description of the simulation study and a discussion of the results
follows in the section below. A more extensive description, as well as the results, is given in
Appendix A.
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5.5.1 Setup
Since the two-stage approach cannot be completely automated, a relatively large
simulated data set was used rather than many simulations based on small data sets. A data
set consisting of 1000 subjects per scenario was simulated. The follow-up period for each
subject was randomly selected between 2 to 8 years equally spaced. The median number of
visits was equal to 5. The data was simulated from a linear mixed-effects model (as described
in Section 2). The methods were compared as described previously. Namely, the classical
one-stage, R-INLA and the H-likelihood approaches were compared and the one-stage and
two-stage approaches were compared. We varied two factors in the simulation study, (1) the
number of levels and (2) the variance of the random effects. This was done for models based
on the one-stage and two-stage approaches. This resulted in 8 different simulations. Upon
convergence, the posterior mean, median, standard deviation with the equal tail 95% credible
interval (CI) for all parameters of interest were computed in order to compare the 4 different
approaches.
5.5.2 Discussion of the simulation study results
Although the estimation procedures differ, the classical one-stage, R-INLA and
H-likelihood approaches produced similar results for all of the simulation studies. However,
better estimates for the slope parameters were obtained using the H-likelihood approach for
the simulations including 3 levels. The true slope parameters were set to be −1 dB/year. For
simulation 3, the slope parameters estimates were −0.95 dB/year, −0.94 dB/year and −0.99
dB/year for the classical one-stage, R-INLA and H-likelihood approaches, respectively. For
simulation 4, these estimates were −1.34 dB/year, −1.29 dB/year and −0.99 dB/year for the
classical one-stage, R-INLA and H-likelihood approaches, respectively. The one-stage and
two-stage approaches produced consistently similar results for all of the simulation studies.
5.5.3 Practical aspects
When analysing this data set, important aspects such as the left-censoring of the data and
Global Visit Effects need to be accounted for (Bryan et al., 2015, 2017). However, for the
comparison of these approaches a simplified model was needed. This was due to the fact
that it is not possible to use censoring or to use a t-distribution on the cross-classified random
effects with R-INLA.
While models using the one-stage, R-INLA and the H-likelihood approaches could all
be run using one program, the two-stage approach needed to run in R first and then in a
’blackbox’ version of OpenBUGS afterwards. Although this approach is computationally
quicker since the data can be split into smaller data sets and run in parallel this additional step
can be inconvenient, especially for simulation studies where a large number of data sets need
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to be analysed.
5.6 Concluding remarks
In this paper we investigated different approaches to model complex high dimensional
longitudinal data. Although the parameter estimates for the real data and simulations are
similar for the different approaches, each method has specific advantages and disadvantages.
The classical one-stage model is a standard method for modelling longitudinal data. However,
this method is time consuming with complex models and large data sets and may also imply
computational difficulties.
The two-stage approach provides a method to overcome the computational difficulties by
allowing the user to split the data into smaller, manageable data sets which can be run in
parallel. This reduces the computational burden. However, this adaptation changes the model
assumptions by allowing the parameters to vary at lower levels. In some cases this may
be in line with the data, however, in other cases when the two-stage is only chosen to reduce
computation time, this may be an unintended side effect. Since this is still a new method, there
are aspects that need to be taken into account. Firstly, if covariates are included in the model
these need to be well thought-out. For example, if factors are the same within one individual,
blocks need to be used. Secondly, the two-stage approach works with a ’blackbox’ version of
OpenBUGS. Currently the only way to perform the second stage is to use a ’blackbox’ version
of OpenBUGS. Hence, it is not possible to use R to call OpenBUGS. For more information on
setting up OpenBUGS for performing the two-stage analyses, we refer to Lunn et al. (2013).
Both the one-stage and two-stage approaches can be used in a great variety of hierarchical
models, not only for Gaussian hierarchical models. Furthermore, they are able to take into
account special features such as a censored response.
R-INLA provides a quick solution, both computationally and with ease of implementation.
This approach allows us to overcome the difficulties with computational time. However,
R-INLA has limitations in what kinds of models can be estimated. For example, it is not
possible to use censoring or to use a t-distribution on the cross-classified random effects.
The H-likelihood approach provides a conceptually simple and reliable inferential procedure
for models with general random effect structures, for example crossed-classified and
multivariate random effects and those with spatial and temporal correlations. Outliers or
model misspecifications can cause a severe bias in parameter estimation (Noh and Lee, 2007).
The use of a heavy-tailed distribution for responses gives robust estimates against outliers
(Noh and Lee, 2007) while that of a heavy-tailed distribution for random effects gives robust
analysis against misspecifications of distributional assumptions on random effects (Lee et al.,
2006). The h-likelihood approach allows both ML and REML analyses and provides various
model checking plots and useful model selection criteria such as conditional AIC for model
selection. The R package dhglm allowing heavy-tailed distributions is available at CRAN
(Lee and Noh, 2016).
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Previous work can be found in the literature comparing combinations of the approaches
discussed in this paper. For example, comparisons between the one-stage and two-stage
approaches (Lunn et al., 2013); R-INLA and OpenBUGS (Carroll et al., 2015) and
H-likelihood and Bayesian approaches (Jin Jang et al., 2007), to name a few. To our
knowledge, there is no current literature comparing the one-stage, two-stage, R-INLA and
H-likehihood approaches. Comparisons with other approaches, such as SAS, are described by
Lesaffre and Lawson (2012). Furthermore, Browne and Draper (2006) show a comparison of
Bayesian and likelihood-based methods for fitting multilevel models. Although these methods
were not in the scope of this paper, further comparisons with other approaches could be
investigated.
In this paper we have described 4 different estimation techniques for modelling complex
hierarchical models. We have investigated the pros and cons for each approach. The decision
for which method to use should depend on the required modelling flexibility, computation
time and ease of implementation.
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5.7 Appendix
5.7.1 Simulation models
The number of levels in the simulated data set was varied from 2 levels (a and b) to
3 levels (a, b and c). Data sets were simulated based on the model used in the one-stage
approach (Models 1 and 2) as well as on the model used in the two-stage approach (Models 3
and 4). For all of the simulations, we let β0 = 30 and β1 =−1.
Model 1:
Two data sets are simulated from the one-stage approach with 2 levels. Let the simulated
response be denoted by yabt . We then simulate yabt for a = 1, . . . ,1000, b = 1,2 and visit
t = 1, . . . ,Ta using,
yabt = α0a +α1ayearsat + γ0ab + γ1abyearsat + εabt (5.7.1)
where,
αa = (α0a,α1a)T ∼ N((β0,β1)T ,Σα )
γab = (γ0ab,γ1ab)T ∼ N((0,0)T ,Σγ ) and
εabt ∼ N(0,σ2).
The variances used to simulate the data were varied to obtain simulated data sets 1 and 2.
More specifically:
Simulation 1:
Σα =
(
10 0
0 10
)
,Σγ =
(
10 0
0 10
)
and σ2 = 1
Simulation 2:
Σα =
(
20 0
0 20
)
,Σγ =
(
20 0
0 20
)
and σ2 = 2
Model 2:
Two data sets are simulated from the one-stage approach with 3 levels. Let the simulated
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response be denoted by yabct . We then simulate yabct for a = 1, . . . ,1000, b = 1,2, c = 1,2,3,
and visit t = 1, . . . ,Ta using,
yabct = α0a +α1ayearsat + γ0ab + γ1abyearsat +
η0abc +η1abcyearsat +λ0abc + εabct (5.7.2)
where,
αa = (α0a,α1a)T ∼ N((β0,β1)T ,Σα )
γab = (γ0ab,γ1ab)T ∼ N((0,0)T ,Σγ );
ηabc = (η0abc,η1abc)T ∼ N((0,0)T ,Ση ) and
εabct ∼ N(0,σ2).
Using this model, and varying the variances, we obtain simulated data sets 3 and 4. More
specifically:
Simulation 3:
Σα =
(
10 0
0 10
)
,Σγ =
(
10 0
0 10
)
,Ση =
(
10 0
0 10
)
, and σ2 = 1
Simulation 4:
Σα =
(
20 0
0 20
)
,Σγ =
(
20 0
0 20
)
,Ση =
(
20 0
0 20
)
, and σ2 = 2
Model 3:
The two data sets are now simulated from the two-stage approach. The model is the
same as in Model 1, however the variance parameters are assumed to differ across individuals
as follows,
αa = (α0a,α1a)T ∼ N((0,0)T ,Σα )
γab = (γ0ab,γ1ab)T ∼ N((0,0)T ,Σγa);
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Using this model, and varying the variances, we obtain simulated data sets 5 and 6. More
specifically:
Simulation 5:
Σα =
(
10 0
0 10
)
,Σγa ∼ N
(
Σ11γa 0
0 Σ22γa
)
and σ2a ∼ N(1,2)
where
Σ11γa = σ11γa ∗σ11γa and σ11γa ∼ N(2,2)
Σ22γa = σ22γa ∗σ22γa and σ22γa ∼ N(2,2)
Simulation 6:
Σα =
(
20 0
0 20
)
,Σγa ∼ N
(
Σ11γa 0
0 Σ22γa
)
and σ2a ∼ N(2,2)
where
Σ11γa = σ11γa ∗σ11γa and σ11γa ∼ N(5,2)
Σ22γa = σ22γa ∗σ22γa and σ22γa ∼ N(5,2)
Model 4:
The two data sets are now simulated from the two-stage approach. The model is the
same as in Model 2, however the variance parameters are assumed to differ across individuals
as follows,
αa = (α0a,α1a)T ∼ N((0,0)T ,Σα )
γab = (γ0ab,γ1ab)T ∼ N((0,0)T ,Σγa);
ηabc = (η0abc,η1abc)T ∼ N((0,0)T ,Σηa)
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The variances used to simulate the data were varied to obtain simulated data sets 7 and 8.
More specifically:
Simulation 7:
Σα =
(
10 0
0 10
)
,Σγa ∼ N
(
Σ11γa 0
0 Σ22γa
)
,Σηa ∼ N
(
Σ11ηa 0
0 Σ22ηa
)
and σ2a ∼ N(1,2)
where
Σ11γa = σ11γa ∗σ11γa and σ11γa ∼ N(2,2)
Σ22γa = σ22γa ∗σ22γa and σ22γa ∼ N(2,2)
Σ11ηa = σ11ηa ∗σ11ηa and σ11ηa ∼ N(2,2)
Σ22γa = σ22ηa ∗σ22ηa and σ22ηa ∼ N(2,2)
Simulation 8:
Σα =
(
20 0
0 20
)
,Σγa ∼ N
(
Σ11γa 0
0 Σ22γa
)
,Σηa ∼ N
(
Σ11ηa 0
0 Σ22ηa
)
σ2a ∼ N(2,2)
where
Σ11γa = σ11γa ∗σ11γa and σ11γa ∼ N(5,2)
Σ22γa = σ22γa ∗σ22γa and σ22γa ∼ N(5,2)
Σ11ηa = σ11ηa ∗σ11ηa and σ11ηa ∼ N(5,2)
Σ22γa = σ22ηa ∗σ22ηa and σ22ηa ∼ N(5,2)
5.7.2 Simulation Results
The results for the simulations comparing the classical one-stage, R-INLA and
H-likelihood approaches are shown in Tables 5.3-5.6. The comparisons between the one-stage
and two-stage approaches are shown in Tables 5.7-5.10.
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Table 5.4: Results from simulation 1
Parameter Simulated One-stage R-INLA H-Likelihood
β0 30.00 30.08 (0.13) 30.01 (0.13) 30.05 (0.13)
β1 -1.00 -1.03 (0.14) -1.05 (0.12) -1.04 (0.13)
σ2 1.00 1.01 1.01 0.98
Σα
(10 0
0 10
) (11.12 −0.55
−0.55 9.46
) (11.03 −0.05
−0.05 9.58
) (9.58 0.03
0.03 9.59
)
Σγ
(10 0
0 10
) (9.50 0.27
0.27 9.73
) (9.43 0.02
0.02 9.59
) (9.71 −0.06
−0.06 9.78
)
Table 5.5: Results from simulation 2
Parameter Simulated One-stage R-INLA H-Likelihood
β0 30.00 30.01 (0.18) 29.94 (0.17) 29.96 (0.19)
β1 -1.00 -0.99 (0.18) -0.86 (0.17) -0.99 (0.18)
σ2 2.00 1.99 2.01 1.99
Σα
(20 0
0 20
) (19.21 −0.15
−0.15 17.22
) (19.96 0.01
0.01 19.01
) (20.13 0.02
0.02 19.58
)
Σγ
(20 0
0 20
) (20.49 0.42
0.42 19.34
) (18.15 −0.05
−0.05 21.23
) (19.42 −0.02
−0.02 19.51
)
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Table 5.6: Results from simulation 3
Parameter Simulated One-stage R-INLA H-Likelihood
β0 30.00 29.96 (0.12) 29.94 (0.13) 29.95 (0.13)
β1 -1.00 -0.95 (0.06) -0.94 (0.13) -0.99 (0.13)
σ2 1.00 0.99 0.99 0.99
Σα
(10 0
0 10
) (10.49 −0.32
−0.32 10.92
) (10.70 −0.02
−0.02 10.19
) (9.55 0.02
0.02 9.88
)
Σγ
(10 0
0 10
) (9.89 −0.11
−0.11 8.74
) (11.27 0.04
0.04 9.48
) (9.87 0.01
0.01 9.83
)
Ση
(10 0
0 10
) (9.56 0.03
0.03 10.64
) (9.43 0.001
0.001 10.56
) (10.55 −0.04
−0.04 10.46
)
Table 5.7: Results from simulation 4
Parameter Simulated One-stage R-INLA H-Likelihood
β0 30.00 29.78 (0.17) 29.78 (0.19) 29.88 (0.19)
β1 -1.00 -1.34 (0.18) -1.29 (0.19) -0.99 (0.18)
σ2 2.00 2.02 2.02 2.01
Σα
(20 0
0 20
) (19.60 1.77
1.77 19.33
) (19.19 0.02
0.02 20.75
) (19.41 −0.02
−0.02 19.41
)
Σγ
(20 0
0 20
) (21.89 −0.71
−0.71 20.20
) (21.83 0.06
0.06 19.23
) (20.78 −0.02
−0.02 19.17
)
Ση
(20 0
0 20
) (20.40 −0.37
−0.37 20.20
) (20.37 −0.02
−0.02 20.20
) (19.72 0.05
0.05 19.41
)
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Table 5.8: Results from simulation 5
Parameter Simulated One-stage Two-stage
β0 30.00 30.12 (0.12) 30.17 (0.11)
β1 1.00 -0.39 (0.10) -0.40 (0.10)
Σα
(10 0
0 10
) (9.10 −0.25
−0.25 9.56
) (10.73 −0.81
−0.81 10.11
)
Table 5.9: Results from simulation 6
Parameter Simulated One-stage Two-stage
β0 30.00 30.05 (0.16) 30.10 (0.16)
β1 1.00 0.46 (0.14) 0.44 (0.14)
Σα
(20 0
0 20
) (19.33 −0.61
0.61 19.00
) (21.4 −1.20
−1.20 19.75
)
Table 5.10: Results from simulation 7
Parameter Simulated One-stage Two-stage
β0 30 29.88 (0.11) 29.86 (0.11)
β1 1.00 0.25 (0.10) 0.26 (0.10)
Σα
(10 0
0 10
) (9.80 −0.27
−0.27 9.48
) (7.96 −0.19
−0.19 8.37
)
Table 5.11: Results from simulation 8
Parameter Simulated One-stage Two-stage
β0 30.00 30.08 (0.15) 30.13 (0.16)
β1 1.00 0.45 (0.14) 0.41 (0.15)
Σα
(20 0
0 20
) (19.22 −1.06
−1.06 19.65
) (20.24 −2.61
−2.61 19.41
)
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CHAPTER6
Global Visit Eﬀects in Point-wise Longitudinal
Modeling of Glaucomatous Visual Fields
This Chapter is based on: Bryan, S.R., Eilers, P.H.C., Lesaffre, E.M.E.H., Lemij, H.G.,
Vermeer, K.A. (2015). Global Visit Effects in Point-wise Longitudinal Modeling of
Glaucomatous Visual Fields. Investigative Ophthalmology & Visual Science, 56(8):4283 –
4289.
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Abstract
Purpose: One of the difficulties in modeling visual field (VF) data is the sometimes
large and correlated measurement errors in the point-wise sensitivity estimates. As these
errors affect all locations of the same VF, we propose to model them as Global Visit Effects
(GVE). We evaluate this model and show the effect it has on progression estimation and
prediction. Methods: VF series (24-2 Full Threshold; 15 biannual VFs per patient) of 125
patients with primary glaucoma were included in the analysis. The contribution of the GVE
was evaluated by comparing the fitting and predictive ability of a conventional model, which
does not contain GVE, to such a model that incorporates the GVE. Moreover, the GVE’s
effect on the estimated slopes was evaluated by determining the absolute difference between
the slopes of the models. Finally, the magnitude of the GVE was compared to that of other
measurement errors. Results: The GVE model showed a significant improvement in both
the model fit and predictive ability over the conventional model, especially when the number
of VFs in a series is limited. The average absolute difference in slopes between the models
was 0.13 dB/year. Lastly, the magnitude of the GVE was more than 3 times larger than the
measureable factors combined. Conclusion: By incorporating the GVE in the longitudinal
modeling of VF data, better estimates may be obtained of the rate of progression as well as of
predicted future sensitivities.
6.1 Introduction
Evaluation of a longitudinal series of visual fields (VF), as measured by standard
automated perimetry (SAP), provides a method to detect glaucoma and to determine
functional deterioration (Flammer and Meier, 2003). One of the difficulties in modeling
VF data is the large measurement variability of VFs, partially due to the inherent subjective
nature of such a test (Heijl et al., 1989; Werner et al., 1989; Kutzko et al., 2000). This large
variability means that in clinical practice, repeated measurements are performed to confirm
real progression.
A learning effect, where the average mean defect significantly decreases between exams,
has been shown to be present in VF testing (Heijl et al., 1989; Gloor and Schmied, 1980; Gloor
et al., 1980; Kulze et al., 1990). Furthermore, test re-test studies have shown that variability
is dependent on defect depth and test location (Heijl et al., 1989).
In glaucoma, variability is presumably related to fatigue effects and response errors.
A fatigue effect, whereby sensitivity estimates decrease during an examination, has been
demonstrated. This effect has been shown to be different between the inferior and superior
hemifields within one eye (Hudson et al., 1994). In addition, this effect may differ between
the first and second eye at the same visit. The number of false-negative answers have been
shown to be higher in eyes with field loss (Bengtsson and Heijl, 2000). It has also been shown
that there is an inverse relationship between variability and sensitivity (Russell et al., 2012).
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That is, there is a large amount of variability in eyes with severe damage.
A common approach to reduce measurement variability is to average multiple
measurements. For example, summary measures such as the mean deviation (MD) have
less variability due to the averaging over the point-wise sensitivity estimates. Other errors,
however, are spatially correlated and affect the whole VF. One group of such errors are
measurable factors, including season, time of day and reliability indices, which have been
evaluated before (Junoy Montolio et al., 2012; Gardiner et al., 2013). Although these factors
are statistically significant, they are rather small and hence only explain a small part of the
observed global variation in VFs. Junoy Montolio et al. (2012) modelled the visit effect with
these known factors. However, we speculate that other transient factors, such as fatigue, lack
of concentration, or delayed reaction time may play a more important role. An example of
the importance of these factors can be seen in Figure 6.1, where all locations have a drastic
decrease in sensitivity in one of a series of visits. From the longitudinal profiles, it is evident
that this decrease is caused by something that affected all VF measurements of that visit,
rather than by actual damage.
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Figure 6.1: Retinal sensitivity estimates over time for each location of the visual field in the left eye of
a single glaucoma patient. A decrease in the sensitivity estimates can be seen in all locations at around
1 year. The longitudinal profile of the MD values over time are shown on the right. The visit-dependent
decrease is also clear at around 1 year for the MD.
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Since all these (as well as possibly other) factors, affect all locations of the same VF, we
propose to take them together and to call and model them as Global Visit Effects (GVE). In this
way, we can account for both the known and the unknown factors. Hence, the GVE accounts
for all factors that affect all measurements of the same eye at each visit. The GVE was
inspired by a similar phenomenon, namely, trend estimation of sea levels for large numbers
of monitoring stations.
We evaluated the GVE by determining the improvement of the model fit due to
incorporating the GVE in the VF model and the effect of including the GVE on estimating the
rate of progression. Furthermore, we determined the improvement of point-wise predictions
for future measurements accounting for the GVE. Finally, we investigated the magnitude and
importance of the GVE by comparing it to influential factors that have been discussed in the
literature.
6.2 Methods
6.2.1 Patients and Data
The analysis was performed on a subset of VF data of individuals from an ongoing study
conducted at the Rotterdam Eye Hospital, The Netherlands; a full description of the data
was provided earlier (Bryan et al., 2013; Erler et al., 2014). All data is available through
the Rotterdam Ophthalmic Data Repository at http://rod-rep.com. In brief, the patients were
followed up approximately twice per year. The VFs were tested by using the Humphrey Field
Analyzer (Carl Zeiss Meditec, Dublin, CA) with the 24-2, white-on-white test strategy by
means of the Full Threshold algorithm. The response variables of interest were the sensitivity
estimates from the 52 VF points (excluding the 2 points that correspond to the blind spot).
All patients gave their written informed consent for participation. The research procedures
followed the tenets set forth in the Declaration of Helsinki. We excluded VFs with unknown
reliability as indicated by the instrument. Additionally, to simplify the evaluation of the
statistical models, we excluded individuals with less than 15 measurements (in either eye).
For those individuals with more than 15 measurements, only the first 15 measurements were
included in the analysis. The resulting data set consisted of 250 eyes from 125 individuals,
resulting in 3750 VFs and 195000 location-specific sensitivity estimates. Descriptive statistics
can be found in Table 6.1.
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Table 6.1: Descriptive statistics of the study sample
Mean Median Interquartile Range
Baseline age (years) 59.7 61.3 53.2 ; 67.1
Baseline MD (dB) -7.8 -5.7 -11.7 ; -2.3
Average change in MD (dB/year) -0.07 -0.04 -0.19 ; 0.13
Follow-up time (years) 7.7 7.6 7.2 ; 8.1
6.2.2 Statistical Modeling
Bayesian models have many advantages over frequentist approaches, such as taking
into account the uncertainty in all parameters. Combined with Markov chain Monte Carlo
computations, they also allow greater flexibility by relaxing the strong parametric assumptions
commonly used in frequentist models. A hierarchical model is able to take into account both
the within subject and between subject variability. Moreover, since both eyes were included
in the analysis, we are able to capitalize on the common features within each eye by taking
into account the correlation between measurements belonging to the same eye. In addition,
any correlation of VF measurements within the inferior and superior hemifields, separated by
the horizontal meridian, was expected to be higher than between hemifields Asman (1992).
Hence, the analysis was done by using a Bayesian hierarchical mixed-effects model (Verbeke
and Molenberghs, 2000; Ntzoufras, 2009; Lesaffre and Lawson, 2012). We modeled the
hierarchical structure of the data using four levels, namely, (1) the individual, (2) the eye (3)
the hemisphere and (4) the location. An example of the mixed-effects model for the four level
data structure can be seen in Figure 6.2(A). Furthermore, censoring was taken into account
at 0 dB (Tobin, 1958), due to the limitation of the device (Anderson and Patella, 1999). We
will refer to this model as the conventional model. To account for the visit-dependent offset
at all locations, or GVE, we included a parameter in the model to capture the offset at every
visit for each eye within each individual. Hence, this effect accounts for factors that affect all
measurements belonging to the same eye at each visit. The impact of this additional parameter
is demonstrated in Figure 6.2(B). This model will be referred to as the GVE model.
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Figure 6.2: (A) The lines represent the estimated evolutions for each of the levels using a hierarchical
mixed-effects model. In this example, only the intercept varies, but the model includes slopes in a similar
way. (B) The GVE works as an offset for all locations belonging to the same VF. This offset is visible at
around 2 years and 6 years in this example.
In classical, one-stage Bayesian hierarchical models, all parameters are estimated
simultaneously. For complex models, obtaining results using this approach can be difficult
or even impossible due to computational issues. In our case, problems were encountered
regarding the running time and computer memory limitations. Thus, the analysis was done
by using a recently proposed two-stage approach (Lunn et al., 2013), which allowed us to
simplify the computation by splitting the hierarchical model at the individual level. Hence,
individuals were analyzed independently before combining them at the population level.
Figure 6.3 illustrates the hierarchical structure divided into the two stages. A full description
of the models and the computational procedure is given by Bryan et al. (2015) (Bryan et al.,
2017).
6.2.3 Model Evaluation
Our aim was to investigate different aspects of the GVE. Namely, how including the GVE
affects the model fit, the estimated progression rate, the prediction of future measurements
and the magnitude and importance of the GVE. To do this, we compared the conventional
model with the GVE model. The models were compared by determining the error for each
sensitivity estimate (predicted minus observed) and by combining these errors into summary
error measures, namely, the root mean squared error (RMSE) and mean absolute error (MAE)
for each model. The 95th percentile of the absolute errors, which is the value below which
95% of the absolute prediction errors may be found, was also computed to compare the
models. Non-parametric Wilcoxon (matched paired when applicable) tests were performed to
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determine whether the differences between the models were significant.
Population
Individual 1 Individual 125
Visit t
Eye 2
Hemifield 1 Hemifield 2
Eye 1
Individual i
Location 27Location 1 Location 52Location 26
First stage
Second stage
Figure 6.3: Illustration of the hierarchical structure of the data divided into the first and second stages as
done in the two-stage approach.
6.2.4 Model Fit
We evaluated the contribution of the GVE by comparing the model fits, for the
conventional model and the GVE model, using the RMSE, the MAE and the 95th percentile
of the absolute errors. An example of the fits for one eye can be seen in Figure 6.4.
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Figure 6.4: Scatter plot representing the retinal sensitivity estimates over time for each location of the VF
in an example (left) eye. The lines represent the model fits for the conventional model (orange) and GVE
model (green).
6.2.5 Effect on Estimated Progression Rate
To compare the estimated progression rate, or slope, of the conventional model and the
GVE model, we first needed to correct for the GVE in the latter model. An example of this
is shown in Figure 6.5. The evaluation of the change in slopes was then done by calculating
the mean absolute difference of the slopes between the conventional and the GVE model.
Additionally, the distribution as well as the 95% confidence interval of the difference between
the slopes of the two models was determined.
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Figure 6.5: A real example showing how the GVE can influence the estimated rate of progression. The
open circles represent the retinal sensitivity estimates over time for 1 location in the VF. (A) The crosses
represent the fitted data using the GVE model, with the transparent green line showing the model fit over
time. The solid green line indicated the slope of the GVE model. (B) The orange line shows the fit for
the conventional model. The green line shows the fit for the GVE model after correcting for the GVE
estimates.
6.2.6 Prediction of future visual fields
To assess the predictive ability of the model, we performed a 5-fold cross validation.
In each fold, the training set included 100 individuals while the testing set contained 25
individuals. Future measurements were then predicted for each location in the VF for each
individual in the testing set. The number of measurements used for the estimation of the
individual-specific effects was varied (3, 6 and 9 measurements), each time predicting the
sensitivity estimate 6 measurements (approximately 3 years) ahead. An example of this can
be seen in Figure 6.6. In each of the examples, the GVE model gave a better prediction for
the future measurement. The GVE model also appeared to be more robust over the number
of measurements included. The models were evaluated by using the RMSE and the 95th
percentile of the absolute errors.
6.2.7 Magnitude of the GVE
Junoy Montolio (2012) showed that the time of day, season, reliability indices (number of
fixation losses, false negatives and false positive), technical experience and follow up period
have a clinically relevant influence on the MD test results (Junoy Montolio et al., 2012). To
determine the magnitude and importance of the GVE, we compared it to these factors. We
excluded technical experience and follow up period due to the lack of data on these factors.
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Figure 6.6: Scatterplots represents the retinal sensitivity estimates over time for 1 location of the VF. The
predictions were done by using (A) 3, (B) 6 and (C) 9 measurements, which are shown as points in the
blue portion of each plot. In each example, the sensitivity estimate 6 measurements ahead, represented
by a cross, was predicted. The lines represent the predictions using 3, 6 and 9 measurements to predict 6
measurements ahead for the conventional model (orange) and GVE model (green).
Hence, we focussed on the time of day, season and the reliability indices. For time of day, the
tests were stratified into four categories: performed before 10:00 AM, between 10:00 AM and
noon, between noon and 2:00 PM, and after 2:00 PM. For season, the tests were also stratified
into four categories, of 3 months each (March-May, June-August, September-November,
December-February), based on the annual variation of retinal sensitivity (Junoy Montolio
et al., 2012). The reliability indices were treated as continuous variables. Reliability indices
include the proportion of fixation losses, the proportion of false positives, as well as the
proportion of false negatives. We will refer to this model as the fixed factor model. An
example of the model fits for one location can be seen in Figure 6.7. We compared the
model fits using the RMSE, MAE and 95th percentile of the absolute errors. Furthermore, we
determined the magnitude of the GVE compared to the factors by calculating their absolute
means. A limitation of the two-stage approach occurs when there is sparse data, such as the
season or time of day. Since each individual was analyzed separately, information could not
be borrowed from the data set as a whole as done in the classical one-stage approach. Due
to this limitation, we used the classical one-stage approach including 50 randomly selected
individuals for this analysis.
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Figure 6.7: Scatterplots representing the retinal sensitivity estimates over time for 1 location of the VF.
The lines correspond to the fits of the 3 models, with much larger effects for the GVE (green) than for
known, fixed factors (blue).
6.3 Results
6.3.1 Model Fit
Table 6.2 lists the root mean squared errors, mean absolute errors and 95th percentile
of the absolute errors for the models, showing that by incorporating the GVE there is an
improvement in the model fit. Both the squared errors and absolute errors were significantly
smaller for the GVE model than for the conventional model (P<0.001, matched paired).
Table 6.2: Comparison of the fitting ability of the models using the root mean squared error (RMSE),
mean absolute error (MAE) and the 95th percentile of the absolute error
Model RMSE (dB) MAE (dB) 95th Percentile (dB)
Conventional model 3.23 2.08 7.01
GVE model 2.97 1.91 6.43
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6.3.2 Effect on Estimated Progression Rate
When comparing the rate of progression between the conventional model and the GVE
model, the mean absolute difference was found to be 0.13 dB/year (P<0.001, matched paired).
Figure 6.8 shows the distribution of the differences, including the mean and 95% confidence
interval.
Figure 6.8: Histogram showing the distribution of the differences between the slopes for the conventional
model and the slopes for the GVE model. Positive values represent more progression (or smaller slopes)
for the GVE model.
6.3.3 Prediction of future visual fields
Table 6.3 lists the RMSE by using 3, 6 and 9 measurements to predict VF sensitivities
approximately 3 years ahead (9th, 12th and 15th measurement, respectively). The GVE model
showed a significant improvement in the predictions compared to the conventional model,
irrespective of how many measurements were used (P<0.001, matched paired). However,
the difference between the models predictive abilities decreased as more measurements were
included. For the conventional model, there was a significant difference between including 3
and 6 measurements (P<0.001) and between including 6 and 9 measurements (P<0.001). For
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the GVE model, these differences were not significant (P=0.08 and P=0.47, respectively).
Table 6.3: Comparison of the predictive ability of the models using the root mean squared error (RMSE),
varying the number of measurements included for the estimation. Each time, the measurement 6 visits
ahead was predicted
Model 3 measurements (dB) 6 measurements (dB) 9 measurements (dB)
Conventional model 5.63 5.31 4.92
GVE model 4.58 4.65 4.67
6.3.4 Magnitude of the GVE
The fits for the conventional model and the fixed factor model were very similar. This can
be seen in Table 6.4, which lists the RMSE, MAE and 95th percentile of the absolute errors
for each model. By including the factors, the model fit was slightly improved compared to the
conventional model (P<0.001, matched paired). The improvement in the fit was much larger
for the GVE model compared to both the conventional model (P<0.001, matched paired) and
the fixed factor model (P<0.001, matched paired).
Table 6.4: Comparison of the fitting ability of the models using the root mean squared error (RMSE),
mean absolute error (MAE) and the 95th percentile of the absolute error
Model RMSE (dB) MAE (dB) 95th Percentile (dB)
Conventional model 3.33 2.14 7.21
Fixed factor model 3.32 2.14 7.18
GVE model 3.07 1.97 6.67
The mean absolute value of each of the factors is shown in Table 6.5, with the most
influential factor being season (0.13 dB). The combined value of all factors was found to be
0.23 dB. In contrast, the GVE was found to be 0.85 dB.
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Table 6.5: Comparison of the fitting ability of the models using the root mean squared error (RMSE),
mean absolute error (MAE) and the 95th percentile of the absolute error
Factor MAE (dB)
Season 0.13
Time of day 0.09
% Fixation losses 0.00
% False positives 0.10
% False negatives 0.02
Combined 0.23
Global Visit Effect 0.85
6.4 Discussion
In this study, we proposed to model measurement errors that affect the point-wise
sensitivity estimates within the same VF as GVEs. By correcting for the GVEs, we accounted
for all measureable factors, both known and unknown, that affect all measurements of the
same eye at each visit. Furthermore, we evaluated this model and showed the magnitude of
the correction for the GVE on progression estimation and prediction of future measurements.
The GVE model showed a highly significant improvement in the model fit compared to the
conventional model. Hence, by taking the GVE into account, we were able to remove a large
systematic component that would otherwise be interpreted as noise and obtain better estimates
of the true rate of progression. The mean absolute difference between the rates of progression
estimated by the conventional model and the GVE model was shown to be 0.13 dB/year. The
distribution was slightly positively skewed. By correcting for the GVE with our model, we
found a predominantly higher rate of progression. In other words, ignoring the GVE may
obscure the true, most often higher, rate of progression. In this analysis, all measurements
were included to determine the difference between the progression rates of the two models.
For this model to be of clinical use, its prediction of future measurements should be better
than of the conventional model. By incorporating the GVE in the model, we indeed
found significant improvements in the predictions. The GVE model provided more robust
predictions than the conventional model, especially when fewer measurements were included.
This could be explained by the fact that the GVE model takes factors into account that may
either decrease or increase the sensitivity estimates. The GVE has less effect on the estimated
slopes when more measurements are included. Thus, the conventional model and the GVE
model become more similar as more measurements are included. In clinical practice, the
number of visual fields is typically quite small, especially when resources are limited and
robust approaches, such as the GVE, are therefore needed to accurately predict glaucomatous
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progression.
The importance of the GVE was compared to factors described in the literature that have
been shown to be significant. The magnitude of the GVE, however, was shown to be more
than 3 times larger than that of the other factors combined (0.85 dB versus 0.23 dB). Our
results on those factors were consistent with those found by Junoy Montolio et al. (2012)
(Junoy Montolio et al., 2012). Of the known factors, we found season to have the largest
effect, with a mean absolute value of 0.13 dB. In agreement with our results, Junoy Montolio
et al. (2012) concluded that the number of false positive answers has the largest, or most
severe, effect out of the reliability indices. In their study, the MD was determined to be
overestimated by 1 dB per 10% of false positive answers. Time of day was found to have a
mean absolute value of 0.09 dB. It has, however, been shown that the 24-hour IOP rhythm
differs between eyes in glaucoma patients (Liu and Weinreb, 2014). Since the patient’s IOP
may affect each eye differently at the same time of day, and will vary between individuals, it
may be of more interest to determine this factor at an eye-specific level, as done with the GVE.
Although the GVE takes both measureable and unmeasurable factors into account, including
the known factors allows some explanation of the variation. Hence, a combination of both the
GVE and the known factors may be beneficial in the modeling of VF data.
In our model, we determined the GVE for each VF. Thus, the GVE differs per eye for each
individual at every visit. In this way, we can take factors into account that affect the two eyes
(of the same individual) differently, such as, for example, the fatigue effect. Since the patient
has VF tests done on both eyes sequentially, the second eye could be more affected by the
lengthy test. Our model can be extended to take the correlation of the GVE between eyes into
account. In that way, we could determine the patient-dependent, as well as the eye-dependent
GVE. Furthermore, the model may be extended to accommodate that some locations may be
affected differently by some of the factors. Although we have shown the effect of the GVE
using an advanced Bayesian two-stage model, it is important to note that the GVE can be
implemented as a random effect in any point-wise longitudinal model.
In comparison to conventional robust regression which is applied at the location level, the
GVE model can be considered a robust approach applied at the VF level. Hence, while the
GVE model is able to distinguish between within- and between-field errors, the conventional
robust model is not able to do so, because both errors combined in a single error term. By
modeling the visit effect explicitly, we exploit the entire VF structure. Hence, the GVE
allows us to obtain important additional information, which is needed in order to make any
conclusions on the instrument, operator, etc. In this way, we also allow "real" progression to
still affect the slope of the model rather than attributing the entire measurement to error as
done with the conventional robust model.
An approach which is related to the GVE is the pattern deviation, which uses the cumulative
distribution to compute a correction (Anderson and Patella, 1999). The 85th percentile
is used to compensate for effects by for instance cataract, which would lead to a general
reduction of retinal sensitivity throughout the VF. Hence, the entire VF height is adjusted to
the 85th percentile. However, with diffuse loss, the entire VF height tends to be overcorrected
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whenever the 85th percentile becomes significantly affected (Artes et al., 2005). The two
approaches differ in how the visit effects are expressed. Namely, the percentile correction is
treated as a fixed term, while the GVE is treated as a random effect. Because we treat the
GVE as a random effect, which has a distribution with mean zero, it is forced to fluctuate
around zero. The fixed term of the percentile model does not impose any constraint and
hence accounts for both the visit effect and the rate of progression/slope. Hence, in contrast
to pattern deviation analysis, the GVE model allows us to estimate the visit effect without
disrupting the estimation of the progression.
In clinical practice it is known that one single VF may not be reliable and confirmation is
sought in the results from future tests. Clustered VF testing has been shown to identify more
rapid progression than evenly spaced follow-up approaches, allowing the clinician to be more
confident that the progression is real (Crabb and Garway-Heath, 2012). Our model is in line
with these findings and confirms that results which deviate from what is expected may be
due to unknown factors that affect the VF measurements on that specific visit rather than
representing actual damage.
In conclusion, the GVE has a substantial effect on the point-wise VF sensitivities. In
longitudinal VF series, correcting for the GVE provided better estimates of the true rates of
progression, which were predominantly higher than with conventional progression analysis.
In addition, shorter VF series were required to arrive at relatively accurate VF predictions than
with conventional modeling. Implementing progression models that incorporate the GVE in
clinical care may therefore improve the clinical management of glaucoma.
Acknowledgments
The authors would like to thank Dimitris Rizopoulos, PhD, for the useful discussions and
suggestions which helped improve this manuscript.
Bibliography
Anderson, D. R. and Patella, V. M. (1999). Automated Static Perimetry. Mosby, 2nd edition.
Artes, P. H., Nicolela, M. T., LeBlanc, R. P., and Chauhan, B. C. (2005). Visual
field progression in glaucoma: total versus pattern deviation analyses. Investigative
Ophthalmology & Visual Science, 46(12):4600.
A˚sman, P. (1992). Glaucoma hemifield test: Automated visual field evaluation. Archives of
Ophthalmology, 110(6):812–819.
Bengtsson, B. and Heijl, A. (2000). False-negative responses in glaucoma perimetry:
Indicators of patient performance or test reliability? Investigative Ophthalmology & Visual
Science, 41(8):2201–2204.
120
BIBLIOGRAPHY
Bryan, S. R., Eilers, P. H. C., Li, B., Rizopoulos, D., Vermeer, K. A., Lemij, H. G., and
Lesaffre, E. M. E. H. (2017). Bayesian hierarchical modeling of longitudinal glaucomatous
visual fields using a two-stage approach. Statistics in Medicine, 36: 1735–1753.
Bryan, S. R., Vermeer, K. A., Eilers, P. H. C., Lemij, H. G., and Lesaffre, E. M. E. H. (2013).
Robust and censored modeling and prediction of progression in glaucomatous visual fields.
Investigative Ophthalmology & Visual Science, 54(10):6694–6700.
Crabb, D. P. and Garway-Heath, D. F. (2012). Intervals between visual field tests when
monitoring the glaucomatous patient: Wait-and-see approach. Investigative Ophthalmology
& Visual Science, 53(6):2770.
Erler, N. S., Bryan, S. R., Eilers, P. H. C., Lesaffre, E. M. E. H., Lemij, H. G., and
Vermeer, K. A. (2014). Optimizing structure and function relationship by maximizing
rorrespondence between glaucomatous visual fields and mathematical retinal nerve fiber
models. Investigative Ophthalmology & Visual Science, 55(4):2350–2357.
Flammer, J. and Meier, E. (2003). Glaucoma: A Guide for Patients, An Introduction for Care
Providers, A Quick Reference. Hogrefe & Huber Publishers, Cambridge, MA, 2nd edition.
Gardiner, S. K., Demirel, S., Gordon, M. O., and Kass, M. A. (2013). Seasonal changes in
visual field sensitivity and intraocular pressure in the Ocular Hypertension Treatment Study.
Ophthalmology, 120(4):724–730.
Gloor, B. and Schmied, U. (1980). Findings in glaucomatous visual fields under observation
using the "Octopus" automatic perimeter. Klin. Monatsbl. Augenheilkd., (176):545–546.
Gloor, B., Schmied, U., and Fassier, A. (1980). Glaucomatous visual fields analysis of
Octopus observation with statistical material. Klin. Monatsbl. Augenheilkd., (117):423–426.
Heijl, A., Lindgren, G., and Olsson, J. (1989). The effect of perimetric experience in normal
subjects. Archives of Ophthalmology, 107(1):81.
Hudson, C., Wild, J. M., and O’Neill, E. C. (1994). Fatigue effects during a single session
of automated static threshold perimetry. Investigative Ophthalmology & Visual Science,
35(1):268–280.
Junoy Montolio, F. G., Wesselink, C., Gordijn, M., and Jansonius, N. M. (2012). Factors that
influence standard automated perimetry test results in glaucoma: Test reliability, technician
experience, time of day, and season. Investigative Ophthalmology & Visual Science,
53(11):7010–7017.
Prediction of Visual Prognosis 121
BIBLIOGRAPHY
Kulze, J. C., Stewart, W. C., and Sutherland, S. E. (1990). Factors associated with a
learning effect in glaucoma patients using automated perimetry. Acta Ophthalmologica,
68(6):681–686.
Kutzko, K. E., Brito, C. F., and Wall, M. (2000). Effect of instructions on conventional
automated perimetry. Investigative Ophthalmology & Visual Science, 41(7):2006–2013.
Lesaffre, E. and Lawson, A. B. (2012). Bayesian Biostatistics. Wiley & Sons, Chichester,
West Sussex.
Liu, J. H. K. and Weinreb, R. N. (2014). Asymmetry of habitual 24-Hour intraocular
pressure rhythm in glaucoma patients. Investigative Ophthalmology & Visual Science,
55(11):7398–7402.
Lunn, D., Barrett, J., Sweeting, M., and Thompson, S. (2013). Fully Bayesian hierarchical
modelling in two stages, with application to meta-analysis. Journal of the Royal Statistical
Society. Series C, Applied Statistics, 62(4):551–572.
Ntzoufras, I. (2009). Bayesian Modeling Using WinBUGS. Wiley & Sons, Hoboken, N.J.
Russell, R. A., Crabb, D. P., Malik, R., and Garway-Heath, D. F. (2012). The relationship
between variability and sensitivity in large-scale longitudinal visual field data. Investigative
Ophthalmology & Visual Science, 53(10):5985–5990.
Tobin, J. (1958). Estimation of relationships for limited dependent variables. Econometrica,
26(1):24–36.
Verbeke, G. and Molenberghs, G. (2000). Linear Mixed Models for Longitudinal Data.
Springer Series in Statistics. Springer New York, New York, NY, 1st edition edition.
Werner, E. B., Petrig, B., Krupin, T., and Bishop, K. I. (1989). Variability of automated
visual fields in clinically stable glaucoma patients. Investigative Ophthalmology & Visual
Science, 30(6):1083–1089.
122
CHAPTER7
Conclusions
123
7. Conclusions
7.1 Concluding Remarks
In this thesis, we explored and developed statistical methods for dealing with high
dimensional and complex data. Specifically, we focused on modeling longitudinal VF data
from glaucoma patients. In this final chapter we conclude with a summary of principal
research contributions in both the statistical methodology and glaucoma research presented
in the preceding chapters with a discussion on possible future extensions.
7.2 Summary
Evaluation of a longitudinal series of visual fields (VF), as measured by standard
automated perimetry (SAP), provides a way to detect early evidence of glaucoma and
to determine functional deterioration. This facilitates the clinician in providing adequate
treatment, which may slow down the disease, possibly even halting its progression. However,
due to the subjective nature of this technique, SAP is prone to large variability. In order to
measure the true progression of the disease, this variability needs to be taken into account.
A simplistic approach to modeling longitudinal VF data is to treat the 52 locations within
each eye for every individual as independent samples. In Chapter 3 we compared different
regression models, which have been previously investigated in the literature. We evaluated
these models with respect to both the fitting and prediction ability for progression in
glaucomatous VFs. The models included classical approaches, as well as robust methods
and models which take into account censoring.
However, a problem with using separate location-specific regression models is that we are
not able to use any information from the data set as a whole. Hierarchical models reduce
the variability, caused by randomness, by accounting for group effects and/or within-group
correlation. In Chapter 4 we extended this work to account for the complex structure of
the data while dealing with censoring and the high measurement variability using advanced
Bayesian hierarchical models.
Nowadays it is often of interest to fit hierarchical models to data that are big both in terms
of volume and complexity. However, it is also recognized that MCMC sampling can become
computationally prohibitive when applying complex models. To overcome these issues, we
applied a recently proposed two-stage approach which allowed us to speed up computations
considerably while still benefiting from the full Bayesian approach. Furthermore, we extended
this approach to allow the calculation of model selection and model evaluation criteria.
Other approaches such as integrated nested Laplace approximation (INLA) and hierarchical
likelihood (H-likelihood) are also attractive alternative options. In Chapter 5 we investigated
and compared these approaches to the classical one-stage and two-stage approaches.
For the clinical application, we proposed to model factors which affect all locations belonging
to the same VF as global visit effects (GVEs). Details and extensive evaluations of the GVE
were shown in Chapter 6. We evaluated this by determining the improvement of the model fit
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due to incorporating the GVE in the model and the effect that this has on estimating the rate
of progression. Furthermore, we determined the improvement of point-wise predictions for
future measurements. Finally, we investigated the magnitude and importance of the GVE by
comparing it to influential factors that have been discussed in the literature.
7.3 Future Research
The work presented in the previous sections provides foundations for interesting
extensions. In the following section, we highlight several important aspects which were not
discussed in the body of this thesis and which provide potentially interesting directions for
future investigation.
7.3.1 Translate the GVE into Clinical Practice
Correcting for the GVE has a number of consequences, including changes in the estimated
progression rate and the expected VFs of future visits. The consequences of these changes are
still insufficiently mapped. An investigation of these changes, for which patients they occur,
and how they would be best used could ultimately improve clinical care. The software that was
used for the development of the statistical models described in this thesis is not straightforward
and would be difficult to use for a non-statistician. In addition, we have focused on processing
off-line VFs, but it would be beneficial to analyze data from a new patient. To allow a better
clinical evaluation, it would be useful to have an implementation of the model built in a web
environment. This would allow the clinical researcher, or clinician, to directly access and
analyse the VFs of a particular patient.
7.3.2 Spatial Nature
An aspect of the data which was only briefly looked at by including the hemifield effect,
is the spatial nature of the data. One could exploit this by capitalizing on the specific spatial
organization of the nerve fibres in the eye. Knowledge about the physiology of the eye,
particularly the topology of the nerve fibres in the retina, suggests that the assumption of
a standard neighbourhood structure (e.g. direct horizontal and vertical neighbours) in the
visual field data is incorrect. Rather, it seems more plausible to define a neighbourhood that is
based on the paths of the nerves (Airaksinen et al., 2008; Denniss et al., 2012). Work has been
done on transforming the data from the original x-y-coordinates to a different space, where
the location is given in coordinates that are based on the geometry of the retinal nerves (Erler
et al., 2014). This could be extended to incorporate the longitudinal nature of the data. Spatial
models such as those used for disease mapping could be explored.
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7.3.3 Structural and Functional Relationship
Both structural and functional tests are routinely used in clinical practice for diagnosis and
monitoring of glaucoma. Functional tests, such as perimetry, represent the most important
clinical endpoint, but are highly subjective and variable. This limits the clinical utility and
these tests often have to be repeated before a clear result is obtained. This means that a
necessary adaptation of the treatment is delayed. Structural tests, provided by several imaging
modalities, are objective, fast and reliable, but it has proven to be difficult to show substantial
correlation with functional tests. Finding a good correlation would have a significant clinical
impact. The research included in this thesis only focused on functional data. It may however
be of interest to combine this with the structural data in order to improve detection of disease
progression. This can be done by using a joint modeling approach (Rizopoulos, 2012). The
formulation of the association structure between the functional and structural measurements
are complicated by the fact that we have serial measurements of these two outcomes. In
particular, it is not directly evident which features of a patient’s longitudinal trajectory of
the structural outcome are most predictive for the functional or vice versa. Some potential
characteristics that we would like to investigate are the level of structural damage, the rate
of progression of the structural damage and suitable summaries of the whole longitudinal
trajectory of the structural damage that could be shown to be related to functional deterioration
at different time points. This approach might contribute to fighting blindness and severe visual
impairment caused by glaucoma.
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Het beoordelen van longitudinale reeksen van gezichtsvelden (visual fields; VFs),
gemeten met standaard geautomatiseerde perimetrie (standard automated perimetry; SAP),
maakt het mogelijk om de effecten van glaucoom in een vroeg stadium te detecteren en
om de functionele veranderingen te bepalen. Dit stelt een clinicus in staat om een adequate
behandeling in te zetten, waardoor de ziekte vertraagd wordt en verdere progressie mogelijk
zelfs wordt voorkomen. Door de subjectieve manier van meten wordt SAP echter geplaagd
door een grote meetvariabiliteit. Om de echte progressie van de ziekte te kunnen meten moet
met deze variabiliteit rekening worden gehouden.
Een eenvoudige benadering om longitudinale VF gegevens te modelleren is de 52 locaties
binnen elk oog te beschouwen als onafhankelijke gegevens. In hoofdstuk 3 hebben we
verschillende regressiemodellen, die eerder in de literatuur beschreven zijn, vergeleken. Deze
modellen werden vergeleken op basis van hoe goed zij de data beschrijven en progressie
voorspellen in glaucomateuze VFs. De modellen omvatten zowel standaard technieken als
robuuste methodes en modellen beide rekening houdende met censurering. Een nadeel
van deze aparte, locatie-specifieke regressiemodellen is dat ze niet de samenhang van de
ooglocaties in rekening brengen. Dit gebeurt wel met hiërarchische modellen. In hoofdstuk
4 hebben we onze methode uitgebreid om rekening te kunnen houden met de complexe
structuur van de data, censurering en de grote meetvariabiliteit, door middel van geavanceerde
Bayesiaanse hiërarchische modellen.
Er is een groeiende noodzaak om hiërarchische modellen te fitten op grote en complexe
datastructuren. Echter Monte Carlo Markovketen (MCMC) methodes zijn inherent
rekenintensief en de huidige computerinfrastructuur van een statistische onderzoeker laat nog
niet toe deze modellen steeds in een aanvaardbare tijdspanne op grote complexe datastructuren
te schatten. Om dit probleem te ondervangen hebben we een tweetrapsmodel, dat recentelijk
is ontwikkeld, toegepast. Hiermee werd de rekentijd sterk beperkt terwijl de voordelen van
een Bayesiaanse aanpak nog steeds gelden. Daarnaast hebben we deze nieuwe methode
uitgebreid zodat modelselectie-criteria hierop konden worden toegepast. Aantrekkelijke
alternatieven, zoals geïntegreerde, geneste, Laplaciaanse benaderingen (integrated nested
Laplace approximation; INLA) en H-likelihood werden onderzocht in hoofdstuk 5 en
vergeleken met conventionele één- en tweetrapsmodellen.
Voor onze klinische toepassing hebben we allerlei gemeten factoren in rekening gebracht,
zowel op subject-als op VF niveau, die een invloed kunnen uitoefenen op het de progressie
van glaucoom. We hebben echter ook een latente variabele in het model die alle VFs zou
kunnen beïnvloeden, genoemd GVE. Dit GVE (global visit effect) representeert een effect dat
zich in de tijd afspeelt en tegelijk op alle locaties in het oog werkt. Een voorbeeld hiervan is de
vermoeidheid van de patient op een bepaalde dag. Zo’n effect kan het predictieproces ernstig
beïnvloeden en moet daarom in rekening gebracht. De details en een uitgebreide evaluatie van
deze GVEs staan beschreven in hoofdstuk 6. We hebben dit geëvalueerd door te bepalen hoe
groot het effect is de verbetering van het model is wanneer het GVE hierin wordt opgenomen
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en wat het effect hiervan is op de schatting van de progressiesnelheid. Daarnaast is gekeken
naar de verbetering van de voorspellingen van punten in het VF. Ten slotte werd de grootte
en het belang van het GVE onderzocht door dit te vergelijken met andere belangrijke factoren
die bekend zijn uit de literatuur.
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